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There is a driving force more powerful than steam, electricity and atomic 
energy: the will. 
 
Albert Einstein 
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Abstract 
 
The determination of lactate in matrices as urine and saliva is challenging due to the 
sample complexity and the low concentration levels to be determined.  This study reports 
the development of a novel method to determine lactate in biological matrices (urine and 
saliva) using a pre-column derivatization procedure with 9-chloromethyl anthracene (9-
CMA) and liquid chromatography (RP-HPLC) with UV detection at 365 nm and 
fluorescence detection at 410 nm (λex = 365 nm). 
The formation of the lactate derivative and by-products was confirmed by LC-ESI-Q-ToF. 
The calibration curve was linear in the investigated range 0.09-15 mM and the limit of 
detection was 0.03 mM for both fluorescence detection and for UV detection.  Intra-day 
and inter-day repeatability were less than 5 and 6 %, respectively. 
 
The calibration curve in urine samples was linear in the investigated range 0.09-15 mM. 
Intra-day repeatability was less than 4% and 5% for fluorescence and UV detection, 
respectively.  Intra-day recoveries were found to be between 92 and 105 % and between 98 
and 106% for fluorescence and UV detection, respectively.  
The calibration curve in saliva samples was linear in the investigated range 0.09-15 mM. 
Intra-day repeatability was less than 2 and 3% for fluorescence and UV detection, 
respectively.  Intra-day recoveries were found to be between 101 and 108 % and between 
104 and 109% for fluorescence and UV detection, respectively.  
The optimized method for the lactate determination was successfully applied to urine and 
saliva samples of healthy volunteers before, after and during training and of patients from 
an intensive care unit.  
The method was further optimized for the analysis of urine samples in order to provide the 
simultaneous determination of lactate and creatinine. 
Hence lactate and creatinine are determined in one chromatographic run, representing a 
great advantage in terms of time of analysis and amount of sample required.  This is the 
first analytical method proposed in the literature able to provide the simultaneous 
determination of lactate and creatinine. 
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Introduction and aim of the study 
 
Lactic acid (2-hydroxypropanoic acid) is a product of anaerobic glycolysis resulting from 
pyruvate by the enzyme lactate dehydrogenase (LDH).  The lactic acid can be found in 
blood and biological fluids of human beings and animals. 
The measurement of lactate in biological fluids is an important tool in sport medicine to 
monitor the maximum performance level of athletes
[1-3]
. 
Lactic acid is indeed the final product of the anaerobic glycolysis and during intense 
exercise its concentration increases because of the switch of muscle cells to anaerobic 
metabolism.  Once a certain level of lactate is reached, exhaustion occurs and there is a 
rapid decline in exercise capacity. 
Lactic acidosis is also found in all diseases involving inadequate intake of oxygen to tissue 
(hypoxia) and this is a spy of organ failure and dysfunction: acute congestive heart failure, 
renal or hepatic failure, respiratory failure, severe pulmonary diseases, pulmonary edema, 
severe anemia, diabetes not under control and a number of rare inherited metabolic and 
mitochondrial diseases (forms of muscular dystrophy, ASL, etc.)
[4, 5]
. 
Hyperlactemia is typical of patients with severe sepsis or septic shock, it can be secondary 
to the anaerobic metabolism due to the hypoperfusion and it has a prognostic value. 
In all these conditions the repeated measurements of lactate at intervals is of fundamental 
importance to keep under control the conditions of the patients also in response to a 
therapy. 
The determination of lactate is usually performed in blood or plasma and based on 
enzymatic methods which are expensive and loss in sensitivity and specificity. 
In the last years the measurement of metabolites in media other than blood is becoming 
very significant because of the demand of non-invasive analysis.  Such measurements are 
very important to avoid physical and mental stress, risk of infection and the presence of 
medical staff.  Matrices as urine and saliva are very useful either to control daily 
parameters in hemophiliacs, neonates and elder patient, either to monitor the training of 
athletes
[6, 7]
.  Indeed, the determination of lactic acid in complex matrices as urine and 
saliva is challenging.  The concentration of urinary and salivary lactate it’s quite small 
(about 0.1-0.3 mM) and the sample has to be diluted to avoid matrix effects.  Furthermore, 
the direct detection of lactate is unspecific because it is based on the intrinsic absorbance at 
Development of a chromatographic method for the determination of lactate in urine and saliva 
8 
 
210 nm.  Thus, a new derivatization agent is required to assure selectivity and sensitivity 
and to control matrix effect.  Moreover, a combined analytical procedure able to 
simultaneously determine the urinary creatinine could allow the comparison of lactate 
levels between different samples.  In clinical laboratories, urinary creatinine is used as a 
standardization tool for the quantitative evaluation of urinary metabolites, in order to avoid 
the interfering influence of the physiological differences in the dilution level of urine.  
The main aim of this study was to develop a novel, straightforward derivatization method 
for the determination of lactate by RP-HPLC with UV and fluorescence detection and to 
optimize an analytical procedure for the simultaneous determination of lactate and 
creatinine in urine samples. 
9-chloromethyl anthracene was chosen as the fluorescence reagent, which has never been 
previously used for obtaining a lactate derivative.  9-CMA can react with lactate with high 
selectivity, without requiring extraction procedures from the aqueous solution, in a very 
short time (the reaction reaches 70% completion in 30 min).  Furthermore, the reaction is 
catalyzed by tetrabutyl-ammonium bromide (TBAB) instead of pyridine or other hazardous 
substances, resulting in a safer analytical procedure. 
The overall work may be summarized as follows: 
- optimization of the derivatization procedure with 9-CMA and comparison with the 
classical derivatization reagent used for lactate determination; 
- demonstration of the formation of the lactate derivative and by-products by HPLC-
ESI-Q-ToF; 
- optimization of the chromatographic conditions (best column, column temperature 
and mobile phase) to guarantee a good resolution and a short time of analysis; 
- application of the optimized method to urine and saliva samples of healthy 
volunteers before, after and during training and of patients from an intensive care 
unit; 
- further optimization of the method to simultaneously determine lactate and 
creatinine in urine samples. 
 
Chapter 1                                                                                                                        State of the art 
9 
 
CHAPTER 1 
 
State of the art 
 
1.1.  Biochemistry of lactic acid 
 
Lactic acid (2-hydroxypropanoic acid) is a product of anaerobic glicolyisis resulting from 
pyruvate by the enzyme lactate dehydrogenase (LDH).  The lactic acid can be found in 
blood and biological fluids of human beings and animals. 
Glycolysis (Figure 1.1) is the metabolic pathway that converts glucose to pyruvate; the 
free energy released in the process is used to form the high-energy compounds ATP and 
NADH.  
 
 
Fig. 1.1: scheme of the glycolysis pathway
[8]
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The pyruvate formed by glycolysis is further metabolized via one of the three catabolic 
routes (Figure 1.2). 
 
 
 
Fig. 1.2: three possible catabolic fates of the pyruvate formed in glycolysis
[8]
 
 
In aerobic conditions, glycolysis is only the first stage in the complete degradation of 
glucose.  Pyruvate is oxidized to yield the acetyl group of the acetyl-coenzyme A; the 
acetyl group is then oxidized completely to CO2 by the citric acid cycle.  The electrons 
from these oxidations are passed to O2 through a chain of carriers in the mitochondrion, to 
form H2O.  The energy from the electron transfer reactions drives the synthesis of ATP in 
the mitochondrion.  In some plant tissues and in certain invertebrates, protists, and 
microorganisms such as brewer’s yeast, pyruvate is converted under hypoxic or anaerobic 
conditions into ethanol and CO2 by the alcoholic fermentation.  
When vigorously contracting, skeletal muscles work under low oxygen conditions 
(hypoxia), pyruvate is reduced to lactate via the lactic acid fermentation.  Under these 
conditions NADH can’t be oxidized to NAD+ , which is necessary for the oxidation of 
pyruvate.  Hence pyruvate is reduced to lactate, accepting electrons from NADH and 
thereby regenerating the NAD
+
 necessary for glycolysis to continue.  The reaction is 
catalyzed by LDH to form the L isomer of lactic acid at pH 7.   
The conversion of glucose to lactate does not involve a net change in the oxidation state of 
carbon (in glucose and lactic acid the H:C ratio is the same) or in the concentration of 
NAD
+
 and NADH.  The two molecules of NADH formed during the glycolysis are used to 
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reduce the two molecules of pyruvate.  Therefore the lactic fermentation is a process in 
which an extraction of energy (ATP) occurs, without consuming oxygen.  
The lactate produced by active skeletal muscles can be recycled, it is carried in the blood to 
the liver, where it is converted to glucose by gluconeogenesis during the recovery from 
strenuous muscular activity (Cori cycle).  The produced glucose is then supplied to the 
muscles through the bloodstream where it can undergo to further glycolysis reactions.  If 
the muscle activity has stopped, the glucose is used to replenish the supplies of glycogen. 
Figure 1.3 shows the Cori Cycle. 
 
 
 
 
Fig. 1.3: Cori cycle
[8]
 
 
A healthy adult man normally produces about 120 g of lactic acid a day.  Among these,    
40 g (33%) are produced by tissues characterized by an exclusively anaerobic metabolism 
(retina and blood red cells).  The remaining 80 g (67%) are produced by other tissues (most 
of all muscle) on the basis of the actual oxygen availability.   
Thus, the determination of lactate concentration level is a good approach to evaluate the 
balance between the oxygen demand of tissues and its use, and it is useful in the study of 
animal and cellular physiology
[8, 9]
. 
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1.2.  Lactic acid in sports 
 
In muscle, during exertion, pyruvate derived from glucose and glycogen is reduced to 
lactate, which is reoxidized and partially reconverted into glucose during rest (Cori cycle).  
The concentration of blood lactate is usually 1–2 mmol/L at rest, but can rise to over 20 
mmol/L during intense exertion because of the switch of muscle cells to an anaerobic 
metabolism.   
The classical explanation of lactate production was that it increases to provide 
supplementary anaerobically derived energy.  However, currently, the predominant view is 
that the role of lactate formation as an energy source is of minor importance.  Instead, it 
has been suggested that the increased lactate production are metabolic adaptations, which 
primarily serve to activate the aerobic ATP production
[10]
 .   
Furthermore, the lactic acid is a strong stimulus to the secretion of anabolic hormones such 
as GH and testosterone.  For this reason high intensity workout combined with short rest 
periods contributes to gain muscle mass.   
However, once a certain level of lactate concentration is reached, exhaustion occurs and 
there is a rapid decline in exercise capacity.  Thus, in sport medicine lactate concentration 
is used to monitor the maximum performance level of athletes
[11]
.  
The maximal lactate steady state (MLST) is considered to be the upper limit of heavy 
intensity domain and represent the higher exercise intensity that can be maintained over 
time without continuous lactate accumulation (the rate of lactate production equals the rate 
of lactate elimination)
[12]
.  Since the lactate concentration is strictly correlated with the 
oxygen demand, the MLST can be evaluated by determining the blood lactate 
concentration, by measuring the heart rates at different loads (Conconi test) or by 
measuring the ventilator parameters.  Generally in untrained athletes the MLST coincides 
with the 55% of the VO2max (maximum oxygen consumption), while in well-trained 
athletes the MLST is reached just at the 85% of VO2max. 
The measurement of ventilator parameter provide accurate results but a very expensive 
instrumentation is required (hemogas analyzer).  The Conconi test is the most used method 
to assess the anaerobic threshold of athletes but it’s not suitable for untrained athletes since 
it is a maximal test.  Furthermore, the interpretation of the results is very complex. 
The determination of blood lactate is performed by enzymatic biosensors collecting the 
blood from a finger or from the earlobe.  This method is invasive and the analysis can be 
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affected by the presence of sweat (in which the lactate concentration is over an order of 
magnitude higher than the blood concentration). 
Figure 1.4 shows typical lactate values over a 30 minutes period for different levels of 
exercise.   
 
 
 
Fig: 1.4: blood lactate trends for six different levels of exercise.  
 
Each line represents a slightly harder effort (from blue to red to green to purple to teal to 
brown).  For the first five effort levels the lactate elimination capability is equal to the 
lactate production: a steady state is reached.  For the sixth level the lactate production is 
higher than the elimination rate and the lactate level continues to rise (no steady state).  
On this basis, it is important to determine the amount of lactate in biological fluids (sweat, 
serum, plasma, saliva, urine, liquor, amniotic liquid...) using simple, cheap, fast, precise 
and accurate methods. 
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1.3.  Lactic acid in Clinics 
 
The increase of lactic acid (lactic acidosis) is a pathological state diagnosed when the 
serum concentration of lactate is persistently over 4 mmol/L (normal lactate concentration 
is 2 mmol/L or lower) and can occur in two conditions: 
 
 Type A: tissue hypoxia (oxygen deficiency) and hypoperfusion (decreased blood 
flow through an organ); 
 Type B: high rate of anaerobic glycolysis (no clinical evidence of hypoperfusion) 
 
In type A lactic acidosis the aerobic pathway, i.e. the oxidation metabolic pathway of 
pyruvate to carbon dioxide and water, is blocked for several reasons.  In particular, oxygen 
deficits (tissue hypoxia) are the most common and often refractory causes of lactic 
acidosis, including pulmonary problems (low PO2), circulatory problems (poor delivery of 
O2), and hemoglobin problems (low O2-carrying capacity, for various reasons).   
This occurs in cardiovascular diseases (ischemia, hypoxemia, anemia) and in other 
diseases.  Patients with hypotension either due to septic, hypovolumic or cardiogenic 
shock, may develop lactic acidosis due to poor perfusion of skeletal muscles and 
overproduction of lactic acid.  The degree of lactic acidosis correlates well with the 
duration and severity of shock and is a prognostic factor in the survival of the patients.   
In type B lactic acidosis the anaerobic glycolitic pathway proceeds at high rate, it causes 
low ATP concentration levels and the pyruvic acid produced accumulates and is reduced to 
lactic acid by LDH.  This occurs during intense exertion and in all conditions of 
decoupling of oxidative phosphorilation, giving accumulation of lactate.  For example this 
occurs in the deficiency of pyruvate dehydrogenase enzyme or in B1 vitamin deficiency, in 
which ATP is produced from fat metabolism, or when the conversion of lactate to glucose 
is slow because of liver or renal diseases or genetic or drug-induced defects in 
gluconeogenesis.  Type B lactic acidosis is associated also with acquired diseases (like 
diabetes mellitus, hepatic failure, septicemia, post cardiopulmonary bypass, renal failure, 
etc.) with some metabolites, drugs and toxins (like acetaminophen, biguanides, cocaine, 
epinephrine, norepinephrine, etc.) and with inborn errors of the mitochondrial respiratory 
chain (glucose-6-phospate dehydrogenase deficiency, fructose-1,6-diphospatase 
deficiency, pyruvate carboxylase deficiency, etc.)
[4, 10, 13-15]
. 
Chapter 1                                                                                                                        State of the art 
15 
 
Metabolic acidosis can also develop during pharmacological treatments, due to the 
exposition to chemical agents and in oncologic patients because cancer cells produce more 
lactate than normal cells even in aerobic conditions
[16, 17]
. 
Lactate measurements on the intensive care units have been widely correlated with the 
mortality of the patients (Figure 1.5)
[18-20]
.  
 
 
 
Fig. 1.5: correlation within mortality rate and lactate levels in patients affected by septic shock
[21]
  
 
There are not specific clinical symptoms of lactic acidosis.  Lactic acidosis should be 
suspected in all critically ill patients who are hypovolumic, hypoxic, in septic or 
cardiogenic shock or if unexplained high anion gap metabolic acidosis is present.  
The major clues leading to the diagnosis of lactic acidosis includes: increased anion gap 
metabolic acidosis, increased level of serum lactic acid, significant acidemia (arterial pH < 
7.35) and decrease in plasma bicarbonate.  The arterial blood gas analysis is performed to 
keep under control these, and others, important vital parameters of the patients.  
The most important therapy in management of lactic acidosis is the correction of 
underlying causes.  For example in hypovolumic or cardiogenic shock, restoration of 
perfusion and adequate tissue oxygenation will reverse lactic acidosis, while in septic 
shock an antibiotic treatment or a surgical drainage are required
[22]
.   
Although much of the world scientific literature is focused on the measurement of blood 
lactate, the non-invasive measurement of lactate in urine and saliva has a great potential in 
the home care of the elderly people and in the follow-up of chronic diseases.  
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1.4.  Lactic acid in food, cosmetics and pharmaceuticals 
 
Lactic acid is important not only in clinical diagnosis and sport medicine but also in others 
application like food quality control, cosmetics preparation, pharmaceutical technologies, 
detergents, etc.  
In food industry lactate measurements are important for the control of fermentation of 
wine, cider, beer and milk products since it influences their flavor, stability and quality and 
it’s strictly correlated with their freshness[23-25].  Even in vegetables, fruits and juices lactic 
acid level is related to stability, storage quality and in some cases it can be a marker for 
fermentation by lactic acid bacteria
[26-28]
. 
In recent years lactic acid has become very useful in cosmetic products.  In fact α-hydroxy 
acids (as lactic, citric, glycolic, tartaric acids, etc.) are used in cosmetic products as 
exfoliants, moisturizers and emollient to correct skin disorders, to increase skin hydration 
and to improve some visible effects of ageing by reducing wrinkles and by stimulating cell 
renewal
[29]
. 
Lactate salts, especially ammonium lactate, are used in many pharmaceutical preparations 
to treat severe dry skin or to mitigate the irritating effects of topical corticosteroids
[30]
. 
Since lactic acid and its salts are readily accepted by the body, lactate is an ideal vehicle 
for introducing therapeutic minerals or drugs.  Polymers and copolymers of lactic acid, as 
poly(DL-lactic acid) and poly(lactic-co-glycolic acid), has been extensively used for 
making systems of delivering therapeutic substances including contraceptive steroids, anti-
cancer drugs, anti-malarial agents, peptide hormones, etc
[31-33]
. 
 
 
1.5.  Determination of lactic acid 
 
Therefore, lactate measurement is an important tool in many research areas.  In literature 
there are lots of different assays able to determine lactic acid because of the heterogeneity 
of matrices where it has to be determinate.  All these matrices are very complex and 
different from each other so they require different pretreatment of sample and different 
detection methods. 
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The main classes of techniques employed to determine lactic acid in complex matrices are:  
 
 Colorimetric methods 
 Enzymatic methods 
 Biosensors 
 Separation methods 
 
 
1.5.1.  Colorimetric methods 
 
The first attempts to measure racemic lactate were colorimetric assays.  These methods 
involved the conversion of lactate to acetaldehyde which is then determined as such or 
colorimetrically after reacting with some color-producing substances
[34, 35]
. 
One of the firsts method consisted in the oxidation of lactic acid by KMnO4 in the presence 
of MnSO4; the resulting acetaldehyde was aerated out of the solution, absorbed in bisulfite, 
and then determined by the Clausen titration method
[36]
. 
Otherwise acetaldehyde could be derivatized with p-hydroxyphenol in the presence of 
copper ions and the resulting color change determined spectrophotometrically
[37]
. 
 
 
1.5.2. Enzymatic methods 
 
Enzymatic method is the most employed to determine lactic acid in biological fluids. 
The assay is based on the formation of pyruvate by oxidation of L-lactate with NAD
+
 
(Reaction 1.1) by a reaction catalyzed by lactate dehydrogenase (LDH).  The same reaction 
can be used either to determine D-lactate using D-lactate dehydrogenase instead of LDH. 
 
1.1) L-lactate + NAD
+
  pyruvate + NADH 
 
Reaction 1.1: enzymatic oxidation of L-lactate to pyruvate by LDH  
 
The concentration of NADH can be determined measuring absorbance at 340 nm and it is 
directly proportional to the concentration of lactate in the sample
[38]
.  To achieve better 
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detection limit, NADH can be quantified by fluorimetric detection (excitation at 340 nm, 
emission at 460 nm)
[39]
 or by bacterial bioluminescent enzymes as NADH/FMN 
oxidoreductase and luciferase
[40]
.  
The conversion of lactate can be improved by removing pyruvate from the reaction 
medium because the equilibrium is in favor of lactate.  The more efficient way to trap 
pyruvate is its conversion to alanine by reacting with glutamate in a reaction catalyzed by 
alanine-2-oxoglutarate aminotransferase enzyme (ALT)
[41]
. 
Another enzymatic assay is based on the oxidation of lactate to pyruvate with lactate 
oxidase (LOX) according to Reaction 1.2. 
 
1.2) L-lactate + O2  pyruvate + H2O2 
 
Reaction 1.2: enzymatic oxidation of L-lactate to pyruvate by LOX  
 
In order to determine lactate the reaction is usually coupled to another one (ancillary 
reaction) in which the hydrogen peroxide formed gives a chemiluminescent oxidation 
reaction with reagents such as lucigenin or luminal, or oxidizes a spectroscopically active 
organic dye.  Alternatively the hydrogen peroxide can be monitored with an enzyme 
electrode.  Quantitation of lactate can also be achieved monitoring the fluorescence of 
lactate oxidase: the fluorescence of the enzyme during the reaction it’s proportional to the 
lactate concentration
[42]
.  
 
 
1.5.3. Biosensors 
 
The use of biosensors in clinical diagnosis has become very important in the last years 
because of the many advantages offered besides classical analytical methods.  The use of 
an appropriate biosensor to monitor a specific analyte represents an important gain in terms 
of time and costs because the classical procedure of analysis is avoided and a continuous 
control of the metabolite is guaranteed.  
The main requirements for an efficient biosensor are: sensitivity, specificity and ability to 
detect the disease with no false negative
[6, 30]
.  
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A biosensor is an analytical device incorporating a biological, or biologically derived 
material, intimately associated or integrated within a physiochemical transducer.  The aim 
is to provide an electronic, or optical, response which is proportional to the concentration 
of the analyte.  The most used sensing materials are enzymes due to their specificity and 
also because the role of enzymes in clinical diagnosis has been known for several years . 
The attachment of enzymes to an insoluble matrix is an essential step in the development 
of biosensors because they have poor stability in solutions.  Numerous techniques of 
immobilization have been developed to enhance enzyme stability and to enable their reuse: 
covalent linkage, physical adsorption, cross-linking, encapsulation and entrapment (Figure 
1.6).  The matrix or support to be chosen for immobilization depends on the nature of the 
biomolecule and on the method of immobilization
[43]
.   
 
 
Fig. 1.6: scheme of enzyme immobilization techniques 
 
Biosensors are classified on the type of signal transduction which can be: optical, 
electrochemical, electrical, magnetic or thermometric.  
The most used are electrochemical biosensor because they can be easily miniaturized due 
to the small distance required between biological material and transducer.  Then they can 
operate even in muddy medium (as biological fluids) and they have shorter response time 
and lower detection limits besides optical biosensors
[44]
.  
 
Biosensors have been widely used for determination of lactate because of the short time 
required for the response.  The main type of biosensors are amperometric and based on 
lactate-oxidase (LOx) or lactate-dehydrogenase (LDH).  In amperometric biosensors the 
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current resulting from the electrochemical oxidation or reduction of an electroactive 
species is measured and it’s directly correlated to the bulk concentration of the analyte[45]. 
Amperometric measurements are usually performed by maintaining a constant potential at 
a working electrode, generally by using an Ag/AgCl or saturated calomel electrodes.  
LOx-based amperometric biosensors are the most widely used configuration and allow the 
determination of H2O2 at the working electrode according to the enzymatic reaction 
(Reaction 1.2).  The electrochemical measurement of hydrogen peroxide involves high 
positive potentials causing strong interferences by many easily oxidizable species like 
ascorbic acid
[46]
.  
When LDH is used as enzyme for lactate detection instead of LOx, an additional co-factor 
as NAD
+
 is necessary and NADH is the species to be detected at the electrode.  Although 
this configuration requires high positive potential either, LDH is less used than LOx 
because many inconvenient occurs.  There is an additional immobilization step required 
because of the presence of the co-factor.  Moreover the reaction takes place through radical 
intermediates giving lack of electrode stability.  Then these biosensors were found to be 
less sensitive because of the low oxidizing potential of NAD
+
 (-500mV vs. SCE at pH 7.0) 
which leads to small reaction yields. 
In spite of these inconveniences there are some strategies to eliminate interferences and to 
improve sensitivity.  One example of interference elimination is the conversion of the 
ascorbate into an electrochemically inert species by using ascorbate oxidase
[47]
. 
To increase the sensitivity multi-enzyme configurations are proposed and based on the 
recycling of the substrate of the reaction leading to signal amplification
[48]
.  In fact the 
problem of the unfavorable reaction equilibrium concerning reactions with LDH can be 
solved by coupling a second enzyme to the first.  Examples are the transformation of 
pyruvate to glutamate by glutamic-pyruvic transaminase or of pyruvate to L-alanine by 
alanine aminotransferase.  The product of the oxidation of lactate is subtracted and so the 
reaction is forced to its product side resulting in higher sensitivity
[49, 50]
.  
In biosensors also lactate dehydrogenase cytochrome has been used to detect lactate.  This 
enzyme is independent of oxygen and external cofactor, representing an important 
advantage during immobilization.  However, lactate dehydrogenase cytocrome suffers 
from some disadvantages as well.  In fact D-lactate is a competitive inhibitor of the 
catalyzed lactate oxidation and pyruvate is a competitive inhibitor of the oxidized enzyme 
at low concentration.  Furthermore, this enzyme is inactive in acidic media so a good 
buffering system is required. Finally lactate dehydrogenase cytocrome is readily saturated 
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by lactate (Kmax = 1.2 mM); therefore a dilution step is required for the determination of 
blood lactate since its concentration lies in the range of 1 mM
[51]
.   
 
 
1.5.4. Separation methods 
 
There are several chromatographic methods which can be used for selective and sensitive 
determination of lactic acid in complex matrices: 
 
 Gas chromatography-mass spectrometry (GC-MS) 
 Capillary Electrophoresis (CE) 
 Ion-Exchange Chromatography (IEC) 
 Liquid chromatography-tandem mass spectrometry (LC-MS/MS) 
 High performance liquid chromatography-diode array/fluorescence detectors 
(HPLC-DAD/FD) 
 
 
1.5.4.1. GC-MS 
 
Determination of lactic acid by GC/MS requires a derivatization step in order to increase 
its volatility by modifying the carboxylic and hydroxylic groups.  This technique has been 
applied to biological matrices as blood, plasma and urine.  The sample pretreatment 
consists in a deproteinization step and an extraction step of the acid, generally by ethyl-
acetate.  The most used derivatization procedure consists in the conversion of the organic 
acid into a silyl-ester and ether by using t-butyl-dimethyl-silyl-cloride
[52]
 and N,O-bis-
(trimethylsilyl)-trifluoro-acetamide (BSTFA)
[53]
, although the last method was found to be 
very irreproducible. 
Separation of lactic acid enantiomers can be achieved by using a chiral derivatization 
reagent on an achiral stationary phase
[35]
.  These derivatives include mainly esters, such as 
(-)-menthyloxycarbonyl-methyl esters, acetyl/(-)-menthyl esters and trifluoroacetyl or 
trimethylsilyl/(+)-3-methyl-2-butyl ester
[54, 55]
. 
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1.5.4.2. CE 
 
Capillary electrophoresis can provide a simple and automated method to detect lactate in 
many kinds of matrices like food, beverage, cosmetics and also biological matrices.  The 
small volume of sample required for the injection and the reduced sample pretreatment are 
the most important advantages of CE for body fluids analysis
[56]
.  Determination of lactate 
is generally achieved in short time with an UV detector, monitoring the absorbance at 200 
nm
[57]
.  
Separation of lactic acid enantiomers can be achieved using chiral selectors in the 
separation buffer as 2-hydroxypropyl-β-cyclodextrin (2-HP-β-CD)[58]. 
 
 
1.5.4.3. IEC 
 
Ion-exchange chromatography is an instrumental technique used for the separation and 
determination of organic and inorganic anions and cations and their determination by a 
conductivity detector.  IEC is particularly useful for the determination of anions from 
organic acids, the existence of which depends on the pH.  This technique is often applied to 
food samples for the quality control of beverages as fruit juices and wines
[59, 60]
. 
 
 
1.5.4.4. HPLC-DAD/ FD 
 
The isolation and quantification of lactic acid, as many others organic acids, in complex 
matrices is challenging because of the presence of lots of endogenous substance which 
may interfere with the detection of the analytes of interest.  The direct detection of lactic 
acid is indeed based on the intrinsic absorbance of the carboxylic group at 210 nm
[61]
.  
There are only few reports about direct detection of lactic acid, which require difficult and 
time consuming extraction procedure
[62]
.  
Lactate can be easily determined by HPLC-DAD without any pretreatment in sweat 
samples because the lactate concentration is high enough to allow a high dilution of the 
sample, eliminating any interference
[1]
.   
Thus, the determination of lactic acid in raw matrices requires highly sensitive and 
selective detection methods.  
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The most advantageous strategy to improve the determination of organic acids by HPLC-
DAD/FD is the chemical derivatization of the carboxylic group with a suitable 
chromophore or fluorophore in order to enhance the UV-Vis absorption or to give 
fluorescence properties. 
The most used labels for carboxylic acid are fluorophores because the obtained derivatives 
can be monitored by both fluorescence and UV-Vis detectors.   
The fluorescence (FL) derivatization methods fall into two categories due to the reaction 
timing before and after the chromatographic separation: off-line pre-column and on-line 
post-column.  The pre-column derivatization is used more frequently than the post-column 
for sensitive detection by HPLC.  In fact post-column derivatization suffers from some 
disadvantages as time and temperature restriction on reaction conditions, interdependence 
between mobile phase and the reaction medium, risk of band-broadening and loss of 
resolution due to post column mixing
[63]
. 
The FL tagging involves the covalent binding formation between the reactive functional 
group of the FL reagent and the analyte.  The most used reagents for FL tagging are listed 
in Table 1.1. 
 
Table 1.1: reagents for FL tagging 
 
Reagents 
Functional 
reactive group 
Matrix Ref. 
Alkyl halides R-X 
river water, serum, blood, 
brain tissue 
[64-68]
 
Hydrazine R-CONHNH2 serum 
[69, 70]
 
Amine R-NH2 blood, plasma, serum 
[71-73]
 
Alcohols R-OH plasma 
[74]
 
Sulfonate R-SO3CF3 mouse brain 
[75]
 
Anthracene derivatives 
Ar-Y (Y = Cl,  Br, 
NH2, OH, 
CH=N
+
=N
-
) 
serum, plasma, soil, mud, 
slurry, fruit juice, rat 
pleural cells 
[76-80]
 
 
Chiral reagents which have an asymmetric center in the structure have been developed for 
the resolution of enantiomers of carboxylic acids.  This is based upon diastereomer 
formation with the reagents before HPLC separation
[81, 82]
.  
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There are only few works published on the determination of lactic acid by HPLC-DAD/FD 
using the FL tagging.  The most used FL reagents are: (+)-1-(9-fluorenyl)-ethyl-
chloroformate ((+)-FLEC)
[54]
, 4-(N,N-dimethylaminosulfonyl)-7-piperazino-2,1,3-
benzoxadiazole (DBD-PZ)
[83]
, 4-nitro-7-piperazino-2,1,3-benzoxadiazole (NBD-PZ)
[84]
 
[85]
, 
(2S)-2-amino-3-methyl-1-[4-(7-nitro-benzo-2,1,3-oxadiazol-4-yl)-piperazin-1-yl]-butan-1-
one (NBD-PZ-Val)
[86]
, α-bromo-acetophenone (α-BAP)[87], 2,4’-dibromo-acetophenone (2-
DBAP)
[88]
, O-(4-nitrobenzyl)-N,N’-diisopropylisourea (PNBDI)[89, 90].  
Table 1.2 summarizes the detection limits and the application fields of the techniques cited 
above. 
 
Table 1.2: detection limits and application matrices of the derivatization technique to determine lactate 
 
FL reagent Matrix 
LOD 
(pmol) 
Linear range 
(mM) 
Ref. 
(+)-FLEC / / / 
[54]
 
DBD-PZ Rat serum 0.300  0.01-20  
[83]
 
NBD-PZ 
Rat urine 
Human serum 
0.050  
25 
/ 
1-10  
[84]
 
[85]
 
NBD-PZ-Val Human plasma 750  0.5-4  
[86]
 
α-BAP Human plasma 36  0.18-6 [87] 
2-DBAP Body tissues 0.034  / 
[88]
 
PNBDI 
Table olives 
Fruit juices 
1.5 
0.68  
0.001-0.011  
0.00014-0.0054  
[90]
 
[89]
 
 
In all these cases the derivatization procedure requires the extraction of lactate from the 
sample and long reaction times, resulting in difficult and time consuming methods. 
Furthermore toxic substances as pyridine are often required to catalyze the reaction 
between lactate and the FL reagent.  
Thus there is a need of a new, simple and fast derivatization method to determine lactate in 
biological fluids. 
 
 
1.5.4.5. LC-MS/MS 
 
Liquid chromatography-tandem mass spectrometry is a useful technique that provides high 
sensitivity and selectivity because of the identification of analytes by their masses and by 
their specific fragments.  
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Hence LC-MS/MS would be the technique of choice for the determination of lactate in 
complex matrices because to avoid several limits typical of HPLC-DAD/FD methods. 
However, the low molecular weight of lactate makes difficult its determination by LC-MS 
and especially by LC-MS/MS, where a fragmentation of the parent ion is required.  
There is only one work about the direct determination of lactate in urine samples by LC-
MS, without the derivatization step, but a difficult and time consuming pretreatment of the 
samples is used
[91]
. 
In order to overcome this problem a derivatization step, before the analysis by LC-MS/MS, 
would be helpful to provide an increase of the molecular mass of the analyte.  
The use of a chiral derivatization reagent as (+)-O,O’-diacetyl-L-tartaric anhydride 
(DATAN) provides the separation and determination of lactic acid enantiomers by UPLC-
MS/MS
[92]
. 
 
 
1.6.  Creatinine 
 
1.6.1. Biochemistry of Creatinine  
 
Creatinine is a metabolic waste product resulting from the non-enzymatic conversion of 
creatine and phosphocreatine, which are fundamental molecules for the energy transfer in 
muscle
[93]
. 
Over 90% of bodily creatine is present in the muscle, with the remainder being in the 
plasma and brain
[94]
.  Creatine is synthesized in the body using glycine, arginine (kidney) 
and methionine (liver) and the main dietary source of creatine is red meat. 
Creatine is converted to phosphocreatine in muscle in a reversible reaction with adenosine 
triphosphate (ATP), facilitate by creatine kinase.  When muscle contractions deplete the 
immediate supply of ATP, the phosphocreatine can rephosphorylate ADP to replenish the 
supply of ATP.  Creatine supplementation has been demonstrated to be effective in 
increasing peak force and peak power during short-duration, high-intensity activity, but to 
have no effect on endurance
[95]
.  
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In muscle tissues creatinine is formed by cyclization and dehydration of creatine and 
phosphocreatine (Reaction 1.3)
[96]
. 
 
 
 
1.3) 
 
 
Reaction 1.3: formation of creatinine by creatine cyclization 
 
Creatinine is excreted by kidneys into the urine and, under normal conditions its excretion 
is relatively constant.  Approximately 2% of the body’s creatine is converted into 
creatinine every day.  Hence the amount of creatinine produced is proportional to the 
muscle mass of individual.  
 
 
1.6.2. Urinary creatinine relevance 
 
Quantification of urinary creatinine is an important tool in clinical diagnosis for several 
reasons.  Patients with muscle wasting disease such as muscular dystrophy exhibit reduced 
concentrations of muscle creatine and decreased excretion of creatinine
[97]
.  Urinary 
creatinine in newborn infants and neonates is also monitored
[96]
. 
Creatinine levels are also correlated with renal function because it is excreted by kidneys. 
Therefore quantification of urinary creatinine is useful to monitor patients with liver 
cirrhosis
[98, 99]
 and renal insufficiency
[100]
. 
In clinical laboratories, urinary creatinine is used as a standardization tool for the 
quantitative evaluation of urinary concentrations of drugs, xenobiotics and metabolites, in 
order to avoid the interfering influence of the physiological differences in urine water 
content
[93]
.  Thus, particularly in forensic toxicology, it is a fairly common practice to 
report drug or drug metabolite concentrations in urine as the ratio drug mass/mg of urinary 
creatinine.  Moreover, determination of creatinine in urine samples can be used to identify 
possible adulteration of the specimen, by dilution or substitution with different liquids
[101]
. 
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The urinary creatinine concentration in the normal population ranges from 2.5 to 23 mM 
depending on age, gender and diet
[93]
. 
In this work the determination of urinary creatinine is useful to allow the comparison of 
lactate levels between different samples.  
 
 
1.6.3. Determination of urinary creatinine 
 
Determination on urinary creatinine can be achieved by several immunoassays or 
enzymatic methods
[102-104]
, capillary electrophoresis
[105, 106]
 and liquid chromatography
[107-
109]
. 
The clinical assay for detection of creatinine is based on the Jaffé reaction. This is a 
colorimetric method used to quantify creatinine levels in blood and urine samples
[96]
. 
Creatinine is combined with an alkaline picrate solution to form an orange-red complex 
(according to Reaction 1.4
[110]
). 
 
 
 
1.4) 
 
 
Reaction 1.4: Jaffè reaction between creatinine and picrate 
 
Spectrophotometric detection of the complex is achieved reading the absorbance at 485 nm 
after 45 or 60 and 180 seconds.  In fact the use of the absorbance increments between the 
two time periods provides higher precision. 
A dilution of the urine sample in distilled water (1:50) is the only pretreatment required. 
There are many interferences which may affect creatinine detection; the most important are 
urea, glucose, lactose, uric acid, acetone, ammonia, creatine and albumin
[111]
.  However 
these compounds do not interfere with creatinine determination up to a concentration of 
10-200 times that of creatinine and urine has fairly low concentrations for most of these 
compounds
[112]
.  
This method is time-consuming and often overestimates the creatinine concentration due to 
the interference of endogenous and exogenous pseudo-creatinine chromogens
[113]
.
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CHAPTER 2 
 
Experimental 
 
2.1.  Chemicals 
 
L-Lactic acid (L-6402, purity 98%), creatinine anhydrous (C4255, purity > 99.0%), acetate 
(51791), butyrate (08089) and proprionate (51716) (1000 mg/L in H2O), 9-chloromethyl-
anthracene (196517, purity > 98%) and tetra-n-butylammonium bromide (426288, purity > 
98%) were purchased from Sigma-Aldrich-Fluka (Milan, Italy), pyruvate sodium salt 
(8593589) from Merk and triethanolamine (purity > 99%) from Ashland Chemical Italiana.  
Stock solutions of L-lactic acid, creatinine and pyruvate were prepared in ultra-pure water 
obtained by a Milli-Q system (Purerlab Pro + Purelab Classic, Millipore, USA).  Stock 
solution of 9-chloromethyl anthracene, tetra-n-butylammonium bromide and 
triethanolamine were prepared in acetonitrile (LC-MS Chromasolv, 34967, purity > 99.9%, 
Sigma-Aldrich-Fluka).  Phosphate buffer solution (PBS) at pH 2.5 was prepared from 
monobasic monohydrate sodium phosphate (BDH Laboratory Supplies, Poole, England) 
and phosphoric acid (345245, Sigma-Aldrich-Fluka). 
Methanol for RP-HPLC was purchased from Carlo Erba (Rodano, MI, Italy).   
 
 
2.1.1. Standard solutions 
 
Lactate standard solutions were prepared by diluting the stock solution in Milli-Q water. 
Six standard solutions were employed for the calibration curves and three of them were 
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used as low, medium and high quality control: 0.05 mM, 0.15 mM (LQC), 0.5 mM 
(MQC), 1.5 mM, 5 mM (HQC) and 15 mM.  
Low, medium and high quality controls were used to evaluate the intra-day and inter-day 
repeatability and recoveries.  
Creatinine standard solutions were prepared by diluting the stock solution in Milli-Q water. 
Eight standard solutions were employed for the calibration curves and three of them were 
used as low, medium and high quality control: 0.05 mM, 0.15 mM, 0.5 mM, 1.5 mM 
(LQC), 5 mM (MQC), 15 mM (HQC), 50 mM and 150 mM. 
Low, medium and high quality controls were used to evaluate the intra-day and inter-day 
repeatability.  
 
 
2.2. Biological samples 
 
All the biological samples (urine and saliva) were provided by healthy volunteers and by 
patients from the intensive care unit of Cisanello Hospital (Pisa) after their consensus. 
Urine samples from healthy volunteers were collected before and after training into a       
10 mL Eppendorf tube, centrifuged at 5000 rpm for 10 minutes (Eppendorf Centrifuge 
5804R) and divided into aliquots of 1 mL.    
Urine samples from the patients of the intensive care unit were collected by an urometer 
for a period of time of one hour and placed in 1 mL Eppendorf tubes.  
Saliva samples were collected by STARSTED Salivette® for Cortisol Testing. 
All the samples were frozen at -20°C until analysis and were found to be stable for more 
than 1 year. 
Urine and saliva samples were made to thaw at room temperature and centrifuged at 14000 
and 3000 rpm for 10 minutes respectively.  The surnatant was pipetted into a 1 mL 
Eppendorf tube and vortexed (Velp Scientifica) for 30 seconds. 
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2.3. HPLC-DAD/FD 
 
An HPLC gradient pump (P4000, ThermoFinnigan) was coupled with a vacuum membrane 
degasser (SCM1000, ThermoFinnigan), an AS3000 autosampler (ThermoFinnigan), a 
UV6000 diode array detector and a FL3000 fluorescence detector (ThermoFinnigan).  
Separations of carboxylic acid derivatives were carried out using a reversed-phase HPLC 
column GEMINI C18 (250 mm x 4.6 mm, 5 μm, Phenomenex), equipped with a guard 
cartridge (KJ0-4282, Phenomenex) with the column temperature set at 40°C.  The mobile 
phase with 65% ACN and 35% water was used and the flow rate was set constant at 0.8 
mL/min.  The chromatographic run was complete in 32 minutes, including a rinsing of the 
column in 100% acetonitrile and the re-equilibrating step (Method 1).  An injection volume 
of 20 μL was used for each sample.  The detection of lactate was performed in absorbance 
at 365 nm and in fluorescence setting the excitation and emission wavelengths at 365 and 
410 nm, respectively.  
For the simultaneous determination of lactate and creatinine an isocratic elution in 20% 
ACN and 80% water was used before the gradient. The chromatographic run was complete 
in 42 minutes (Method 2) and the detection of creatinine was performed at 234 nm. 
 
The direct determination of lactate (to estimate the derivatization yield) was carried out 
using a reversed-phase HPLC column Synergi-Hydro RP-C18 (250mm x 4.6mm, 4μm, 
Phenomenex), equipped with a guard cartridge (KJ0-4282, Phenomenex) with the column 
temperature set at 30°C.  The mobile phase with 99% 0.05 M PBS (pH = 2.5) and 1% 
methanol was used and the flow rate was set constant at 0.8 mL/min.  The 
chromatographic run was complete in 30 minutes, including a rinsing of the column in 
100% methanol and the re-equilibration step (Method 3).  The injection volume was 20 µL 
and detection was performed at 210 nm
[1]
.  The lactate calibration curve was linear in the 
investigated range 0.01-30 mM and the detection limit and the quantification limit were 
0.0001 and 0.0004 mM respectively (calculated as 3 and 10 times the standard deviation of 
the blank).  
Table 2.1 summarizes the three elution methods employed. 
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Table 2.1: the three elution methods employed for the determination of: A) lactate derivative, B) lactate 
derivative and creatinine, C) lactic acid 
A) 
Elution method 1 
Time (min) % ACN % Water 
0 65 35 
10 65 35 
11 100 0 
21 100 0 
22 65 35 
32 65 35 
B) 
Elution method 2 
Time (min) % ACN % Water 
0 20 80 
4 20 80 
5 65 35 
16 65 35 
17 100 0 
27 100 0 
28 20 80 
42 20 80 
 
C) 
Elution method 3 
Time (min) % PBS % Methanol 
0 99 1 
7 99 1 
8 1 99 
18 1 99 
19 99 1 
30 99 1 
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2.4. HPLC-ESI-Q-ToF 
 
Analyses were carried out using a 1200 Infinity HPLC (Agilent Technologies, USA), 
coupled by a Jet Stream ESI interface (Agilent) with a Quadrupole-Time of Flight tandem 
mass spectrometer 6530 Infinity Q-ToF detector (Agilent Technologies).  Column 
temperature was 40 °C. 
The ESI operating conditions were: drying gas (N2, purity >98%): 350 °C and 10 L/min; 
nebulizer gas 35 psig; sheath gas (N2, purity >98%): 375 °C and 11 L/min.  Collision gas 
for MS/MS analysis was nitrogen (purity 99.999%). 
High resolution MS spectra were acquired in positive mode in the range 100–1700 m/z, 
while tandem MS/MS spectra were acquired in the range 85-600 m/z.  The data were 
collected with a MS scan rate of 1.46 spectra/s.  The mass axis was calibrated using the 
Agilent tuning mix HP0321 (Agilent Technologies) in acetonitrile. 
Mass spectrometer control and data acquisition were performed with MassHunter
®
 
Workstation Software (B.04.00). 
 
Two different chromatographic methods were used for different columns. 
 
- Method 4 
Separations of carboxylic acid derivatives and creatinine were carried out using a 
reversed-phase HPLC column GEMINI C18 column (250 mm x 4.6 mm, 5 μm, 
Phenomenex), equipped with a guard cartridge (KJ0-4282, Phenomenex). 
The injection volume was 4 μL and the needle wash injection type was used.  The 
flow rate was 0.4 mL/min. 
Table 2.2 A), B) and C) shows the elution method used, the time acquisition 
segments and the scan source parameters, respectively  
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Table 2.2: (A) The elution method used for the determination of  lactate derivative and creatinine; 
(B) time acquisition segments; (C) the scan source parameters for time segment #2 and #4 
 
A) 
Elution method 4 
Time (min) % ACN % Water 
0 20 80 
6 65 35 
32 65 35 
33 100 0 
53 100 0 
54 20 80 
74 20 80 
 
  (B) 
Time 
Segment 
Start Time 
(min) 
Diverter Valve 
State 
1 0.0 Waste 
2 5.0 MS 
3 7.5 Waste 
4 25 MS 
5 40 Waste 
 
C) 
 Time Segment #2 Time Segment #4 
Parameter Value (V) Value (V) 
Capillary voltage 4500 3500 
Nozzle voltage 1000 1000 
Fragmentor 150 100 
Skimmer 1 65 65 
Octopole RF 750 750 
 
 
 
- Method 5 
Separations of carboxylic acid derivatives and creatinine were carried out using a 
reversed-phase Zorbax Extend C18 column (2.1 mm x 50 mm, 1.8 µm) with a 
Zorbax Extend C18 guard column (2.1 mm x 12.5 mm, 5 µm). 
The injection volume was 1 μL and the needle wash injection type was used.  The 
flow rate was 0.3 mL/min. 
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Table 2.3 A), B) and C) shows the elution method used, the time acquisition 
segments and the scan source parameters, respectively.  
 
 
Table 2.3: (A) The elution method used for the determination of  lactate derivative and creatinine; 
(B) time acquisition segments; (C) the scan source parameters for time segment #1 and #3 
 
A) 
Elution method 5 
Time (min) % ACN % Water 
0.8 20 80 
1 65 35 
3.4 65 35 
4 100 0 
7 100 0 
7.5 20 80 
10 20 80 
 
B) 
Time 
Segment 
Start Time 
(min) 
Diverter Valve 
State 
1 0.0 MS 
2 1.0 Waste 
3 5.5 MS 
4 7 Waste 
 
C) 
 Time Segment #1 Time Segment #3 
Parameter Value (V) Value (V) 
Capillary voltage 4000 3500 
Nozzle voltage 1000 1000 
Fragmentor 150 70 
Skimmer 1 65 65 
Octopole RF 750 750 
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2.5. Analytical procedure 
 
The final analytical procedure optimized in this work is summarized in Figure 2.1. 
 
 
 
Fig. 2.1: scheme of the final optimized analytical procedure 
 
Lactate standard solutions and biological samples were thaw at room temperature. 
Biological samples were centrifuged at 14000 rpm for 10 minutes. 
Briefly, 10 μL of sample were added to the reaction vial with 20 μL of 5% TEA, 90 μL of 
90 mM TBA, 370 μL of 10 mM 9-CMA and 10 μL of ACN.  
The reaction solution was incubated at 70°C for 30 minutes in a thermostatic water-bath in 
the dark to facilitate derivatization.  The reaction solution was cooled at room temperature 
and diluted 1:10 in mobile phase prior injection in HPLC.  
For the analysis with HPLC-ESI-Q-ToF all the samples were filtered through a PTFE 
syringe filter (0.45 μm, GRACE). 
 
 
 
 
 
10 μL STD/Sample
+ 370 μL 9-CMA (10 mM) + 90 μL TBA (90 mM) + 20 μL TEA (5%) + 10 μL ACN
Heating at 70 C for 30 minutes
Dilution 1:10 in mobile phase
Injection in HPLC
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2.6. Data processing 
 
ChromQuest
TM
 4.2 Chromatography Data System was used to carry out HPLC-DAD/FD 
control, data acquisition and data analysis.  
MassHunter
®
 Workstation Software (B.04.00) was used to carry out mass spectrometer 
control, data acquisition and data analysis of the analysis in HPLC-ESI-Q-ToF. 
Excel 2007 by Microsoft Corporation and OriginLab Origin 8.6® Corporation  were used 
for the statistical treatment of the data.  
 
 
Development of a chromatographic method for the determination of lactate in urine and saliva 
37 
 
 
Results 
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CHAPTER 3 
 
Optimization of the method 
 
3.1.  9-chloromethyl anthracene 
 
9-chloromethyl anthracene (Figure 3.1) was chosen as the derivatization reagent: 
 
 
 
Fig. 3.1: 9-chloromethyl anthracene 
 
9-chloromethyl anthracene (9-CMA) is an anthracene derivative useful for the 
derivatization of carboxylic acids, phenols, thiophenols and mercaptans. 
The physical-chemical properties of 9-CMA are summarized in Table 3.1
[114]
. 
 
Table 3.1: 9-CMA properties 
 
Empirical formula C15H11Cl 
Molecular weight 226.70 
Melting point 138-140 °C 
Boiling point 402 °C at 760 mmHg 
Appearance yellow powder 
Sensitive Light sensitive 
Chemical stability 4 °C at dark for 1 month 
CAS number 24463-19-2 
Hazard Codes Xi 
Risk Statements 36/37/38 
Safety Statements 26-36 
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9-CMA is a fluorescent compound with a strong absorption at 256 nm.  Figure 3.2 shows 
the UV-Vis absorption spectrum (A) and the fluorescence spectrum (λex: 256nm) (B) of a 
9-CMA solution in ACN. 
 
A) 
 
 
B) 
 
 
Fig. 3.2: UV-Vis absorption spectrum (A) and the fluorescence spectrum (λex: 256nm) (B) of a 9-CMA 
solution in ACN  
 
256 
365
410
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9-CMA has been used for the derivatization of long chain carboxylic acids
[115]
, as fatty and 
bile acids, and for some organic acids (i.e. formic, acetic, proprionic, butyric , pentanoic 
and benzoic acids) in food samples
[76]
. 
Carboxylic acids react with 9-CMA to form fluorescent esters according to Reaction 3.1: 
 
 
 
3.1) 
 
 
 
 
Reaction 3.1: reaction of carboxylic acids with 9-CMA 
 
The reaction is a nucleophilic substitution that proceeds in aprotic solvents (as acetonitrile 
or cicloexane) to avoid the protonation of carboxylates and because of the low solubility of 
9-CMA in protic solvents. 
The reaction must be also catalyzed by a phase-transfer catalyst as tetra-n-butylammonium 
bromide or hydroxide to form an ion pair with the carboxylate to make it soluble in the 
aprotic solvent.  In order to improve the derivatization yield the reaction solution must be 
heated for a desired time. 
The obtained esters have the same spectroscopic properties of 9-CMA and so can be 
detected easier and with higher sensitivity than the correspondent carboxylic acids
[115]
. 
 
 
3.2.  Reactivity of 9-CMA with lactate 
 
The method was first applied to standard solutions of lactic acid (in water) to check if the 
analyte reacts with 9-CMA.  Xie et al.
[76]
 employed 9-CMA to derivatize several 
carboxylic acids with the procedure described in Figure 3.3. 
 
Chapter 3                                                                                                   Optimization of the method 
41 
 
 
 
Fig. 3.3: scheme of the analytical procedure proposed by Xie, et al. 
 
As lactic acid is quite different from the carboxylic acids previously derivatized because of 
the presence of a hydroxilic group in α to the carboxylic group, we first verified its 
reactivity in the same conditions.  This was not granted because in basic media the 
formation of an intramolecular H-bond in lactate molecule occurs (Figure 3.4) leading to a 
stable 5-terms cycle that may makes difficult for lactate to react.   
 
 
Fig. 3.4: intramolecular H-bond 
 
Extraction with 500 μL ethyl-acetate (x 3)
Organic phase + 20 μL TEA (5%)
Dried under N2
500 μL sample + 500 μL HCl 2M
+ 50 μL 9-CMA (10 mM) + 450 μL TBA (20 mM)
Heating at 75 C for 50 minutes
Dilution 1:10 in mobile phase
Injection in HPLC
H
O
O
-
CH3
O
Chapter 3                                                                                                   Optimization of the method 
42 
 
Standard solutions of lactic acid, prepared by dilution from the stock solution, were 
extracted and derivatized as explained in Figure 3.3.  Briefly, an aliquot of the lactate 
standard solution was diluted 1:1 with 2 M HCl.  The analyte was extracted in ethyl-acetate 
and vortexed for 3 minutes.  The procedure was repeated three times and the supernatant 
solvent was collected.  The organic layer was evaporated to dryness in a vial under a 
stream of nitrogen at 40 °C after adding 20 μL of triethanolamine solution (5% in acetone) 
in order to obtain the lactate.  450 μL of 20 mM TBAB in ACN were added to the residue 
and successively 50 μL of 10 mM 9-CMA solution in ACN.  The use of the phase reagent 
transfer (TBAB) is fundamental to form an ion-pair with the carboxylate making it soluble 
in ACN.  The reaction solution was kept at 75°C for 50 minutes in a thermostatic water-
bath in the dark to facilitate the derivatization.  The reaction solution was cooled at room 
temperature and diluted 1:10 in the mobile phase prior to the injection in HPLC.  
Figure 3.5 shows the fluorescence chromatogram at 410 nm (λex = 256 nm) of 0.5 mM and 
a 2 mM lactate standard solutions extracted and derivatized as explained above.  
 
  
Fig. 3.5: Fluorescence chromatogram at 410 nm (λex = 256 nm) of 0.5 mM (red line) and a 2 mM (black line) 
lactate standard solutions  extracted and derivatized with 9-CMA
[76]
 . 
Chromatographic conditions: Synergi-Hydro RP-C18 (250x4.6mm, 5μm, Phenomenex), isocratic elution 
with 64% ACN, 36% Milli-Q water 
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The anthrylmethyl ester derivative of lactate elutes at 6.5 min well separated from the peak 
of the 9-CMA excess (tR = 5.4 min). 
These results show that lactic acid can react with 9-CMA and elutes in a very short time. 
[1][1][1][1][1][1][1][1][1][1][1][1][1][1][1][1][1][1][1][1][1][1][1][1][1][1] 
 
 
3.3.  Optimization of the analytical procedure 
 
Once proved that lactic acid reacts with 9-CMA the derivatization procedure was 
optimized. 
 
 
3.3.1.  Extraction  
 
The extraction of the analyte is a crucial step of the analytical procedure proposed by Xie 
et al..  This requires the elimination of water from the reaction media and a great part of 
endogenous compounds which may be found in the raw matrices analyzed.  Hence, the 
extraction of analytes should lead to a higher selectivity of the method and to a control of 
the matrix effect. 
However, in the specific case of lactate, the extraction suffers of several disadvantages.  
Lactate is very soluble in water and it is difficult to find an adequate extraction solvent.  
Several solvents were assayed to extract lactic acid from an acidic aqueous solution and 
ethyl-acetate was found to be the best solvent but with a 20% extraction yield.   
Furthermore, the extraction is time consuming and it is desirable to limit the sample 
handling in order to reduce the risk of infection for the operator. 
 
For all these reasons we tried the derivatizaton of lactate by adding an aliquot of the 
aqueous lactate standard solution to the reaction vial with TEA, TBAB and 9-CMA in 
ACN (10 µL in 500 µL final volume).  Figure 3.6 shows the fluorescence chromatogram at 
410 nm of 1 mM standard solution of lactate derivatized as reported above without the 
extraction procedure and a corresponding blank solution obtained by applying the same 
derivatization procedure to 10 μL of ultrapure water. 
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Fig. 3.6: Fluorescence chromatogram at 410 nm (λex = 365 nm) of 1m M standard solution of lactate 
derivatized with 9-CMA without the extraction procedure (blank= red line; 1 mM lactate= black line).  
INLET: zooming between 6 and 9 min.  Chromatographic conditions: Synergi-Hydro RP-C18 (250x4.6mm, 
5μm, Phenomenex), isocratic elution with 64% ACN, 36% Milli-Q water 
 
According to the chromatogram lactate reacts with 9-CMA even in the presence of traces 
of water.  However, two peaks (tR 5.7 and 6.5 min) appear when a lactate standard solution 
is derivatized without extraction: the peak at 6.5 min has the retention time of the 
derivatized lactate (see Figure 3.5).  The peak at 5.7 min corresponds likely to a by-
product of the reaction.   
The blank chromatogram evidences also the presence of a small peak eluting at the lactate 
derivative retention time.  This peak does not affect the determination of lactate because it 
has been minimized in the optimization step (see Paragraph 3.3.3.). 
A further experiment in order to study the origin of the by-product peak was performed by 
applying the same derivatization procedure to a lactate standard solution prepared in ACN.  
Figure 3.7 shows the fluorescence chromatograms at 410 nm of 1 mM standard solution of 
lactate derivatized from an aqueous (red line) and ACN (black line) standard solution.  
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Fig. 3.7: fluorescence chromatograms at 410 nm (λex = 365 nm) of 1 mM standard solution of lactate 
derivatized from an aqueous (red line) and ACN (black line) standard solution.  INLET: zooming between 13 
and 21 min.  Chromatographic conditions: Gemini C18 (250x4.6mm, 5μm, Phenomenex), isocratic elution 
with 50% ACN, 50% Milli-Q water 
 
Considering the different chromatographic conditions employed for this experiment, we 
confirmed that the peak at 20.05 min (at 6.5 min in Figure 3.6) is due to lactate derivate 
and the peak at 18.03 (at 5.7 in Figure 3.6) is due to the by-product. 
Probably the peak at 5.7 min corresponds to a by-product of a decomposition reaction of 
the lactate derivative.  In fact the lactate derivative is an ester which may hydrolyze, during 
the heating time, to 9-hydroxymethyl anthtracene (9-OHMA) and lactate (Reaction 3.2) in 
the basic reaction medium. 
 
 
3.2) 
 
 
 
 
 
 
Reaction 3.2: possible hydrolysis of the lactate derivative 
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This hypothesis was confirmed by the analysis with HPLC-ESI-Q-ToF (see Chapter 4).  
The experiment also showed that the area of the lactate derivative peak is double when 
lactic acid is dissolved in ACN instead of water.  
 
 
3.3.2.  Yield of the reaction 
 
The reaction yield was investigated by determining the free lactate in the reaction vial by 
using Method 3 (see Paragraph 2.4)
[1]
.  
The derivatized lactate standard solutions were diluted 1:10 in the mobile phase and 
injected in the HPLC.  Table 2.2 summarizes the concentrations of free lactate found in 
five different derivatization experiments performed at five different concentration levels of 
lactate and the corresponding reaction yields.  
 
Table 2.2:  yield of the derivatization reaction of lactate with 9-CMA for five different concentration levels 
of lactate 
 
[lactate]/mM Reaction yield % 
0.1 70 
0.03 72 
0.01 82 
0.003 88 
0.001 76 
 
The yields ranged between 70 and 88%.  However, when lactic acid was dissolved in ACN 
instead of aqueous medium, the free lactate was one half and the yields ranged among 85 
and 97%.  This confirms the result presented above (see Figure 3.7, Paragraph 3.3.1.) 
 
In summary: i) the lactate reacts with 9-CMA also in the presence of trace amount of 
water; ii) the reaction yield in the presence of trace of water is 80% instead of 95% in 
ACN, thus  the extraction step can be by-passed.  
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3.3.3.  Effect of reaction time 
 
The effect of reaction time was studied at 75 °C (Xie, et al.
[76]
) to determine the minimum 
time required to reach a plateau.  Figure 3.8 shows the peak area of lactate derivative in 
the fluorescence chromatogram (λex = 365 nm, λem = 410 nm) as a function of time.   
 
 
Fig. 3.8: effect of reaction time at 75 °C for a 0.05 mM lactate standard solutions derivatized with 0.1 mM   
9-CMA (injected concentrations) 
 
The reaction reaches a plateau after about 2.5 hours.  Lactate and 9-CMA can react also at 
room temperature but the plateau is reached after about 20 hours.  
 
 
3.3.4.  Optimization of the temperature and reaction time using the 
experimental design 
 
The reaction yield can be affected by several parameters: temperature, reaction time, 9-
CMA excess, TBAB concentration, TEA concentration. 
As the reaction temperature plays an important role in the reaction yield first we performed 
a central composite design with two factors (temperature and time) at five levels (Figure 
3.9). 
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Fig. 3.9: experimental design with two factors (temperature and time) at five levels for the optimization of 
the reaction yield of lactate with 9-CMA 
 
 
Table 3.3 shows the concentrations of the reagents employed, on the basis of Xie et al.
[76]
. 
 
Table 3.3: concentrations of the reagents employed, on the basis of Xie et al.
[76]
 
 
Parameter Value 
[lactate] 0.05 mM 
9-CMA excess 2:1 
[TBAB] 16.2 mM 
[TEA] 10.8 mM 
 
All the thirteen experiments were performed on 0.05 mM lactate standard solutions 
(injected concentration) and on a blank solution.  Figure 3.10 A) and B) shows the 
response surfaces obtained by plotting the area of the lactate and blank peaks of 
fluorescence chromatograms (λex = 365 nm, λem = 410 nm) as a function of reaction time 
and temperature.  The response surfaces were obtained with Origin by converting the raw 
data into a 100x100 matrix using a Random (Renka Cline) gridding method.  Response 
surfaces were calculated not only for the lactate derivative but for the unknown peak of the 
blank that has the same retention time of the lactate derivative (Figure 3.6, Paragraph 
3.3.1).  The unknown peak of the blank increases as the 9-CMA excess increases and it is 
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not negligible for low lactate concentrations.  Thus, the response surface of the blank 
solution is very important in order to minimize this peak.  
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                          B)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.10:  response surfaces obtained from the experimental design (factors: temperature and heating time)   
of a 0.5 mM lactate standard solution (A) and of blank solution (B).  The reagent concentrations were: 1 mM 
9-CMA, 16.2 mM TBAB, 10.8 mM TEA.  Chromatografic conditions: Synergi-Hydro RP-C18 (250x4.6mm, 
5μm, Phenomenex), isocratic elution with 64% ACN, 36% Milli-Q water 
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The results show that the signal increases as the time and temperature increases.  However, 
for temperatures higher than 80 °C many peaks appear in the chromatogram indicating the 
massive formation of by-products/degradation products.  In fact, at 90°C the signal 
decreases as the reaction time increases.  
We designated 70 °C and 1.5 h reaction time as the best derivatization conditions, which 
provide the maximum signal and minimize the risk of degradation.  
However, in these conditions (70 °C for 1.5 h) the unknown peak of the blank solution 
reached a maximum as well (Figure 3.10 (B)).  Hence, we selected 70 °C for 30 min as the 
best derivatization conditions to get only about 7% less of lactate derivative peak and 22% 
less of the blank peak.  Furthermore a shorter reaction time provides a faster procedure.  
 
 
3.3.5.  Optimization of 9-CMA excess 
 
The concentration of 9-CMA is critical for the derivatization reaction and the effect of 9-
CMA excess on the derivatization yield was studied.  
A 0.5 mM lactate standard solution was derivatized for 30 min at 70 °C with 9-CMA by 
varying the 9-CMA/lactate ratio in the range of 1-10.  Figure 3.11 shows the trend of the 
area of lactate derivative peak in the fluorescence chromatogram (λex = 365 nm, λem = 410 
nm) as a function of 9-CMA/lactate ratio. 
 
 
Fig. 3.11: trend of the area of lactate derivative peak in the fluorescence chromatogram 
(λex = 365 nm, λem = 410 nm) as a function of 9-CMA/lactate ratio 
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The signal reached a maximum for 9-CMA/lactate ratio higher than 5.   
For our experiments we chose the maximum concentration of 9-CMA compatible with the 
solubility of 9-CMA in ACN (saturated stock solution) in order to get the maximum 
dynamic linear range in the lactate determination, which corresponded to 7.4 mM 9-CMA 
in the reaction medium.   
 
 
3.3.6.  Doehlert design for the simultaneous optimization of [TEA], 
[TBAB] and [9-CMA] 
 
The Doehlert designs can be used in optimization processes because they offer a uniform 
distribution of points over the whole experimental region.  In the case of three-variables 
designs, a cuboctahedron (a cube with eight vertices symmetrically truncated producing 
eight equilateral triangles whose edges are equal to those of the remaining squares) is 
produced geometrically (Figure 3.12).  
 
 
 
Fig. 3.12: 3D view of the experimental domain in the three variables Doehlert design, the dots represent the 
experiments required
[116]
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The Doehlert designs require the same number of experiments, N, related to the number of 
variables under study, k, as do Box-Behnken designs (N = k
2
 + k + 1) and a lower number 
than ones used in central composite designs (N = 2k
2
 + 2k + 1).  Furthermore, in both 
central composite and Box-Behnken designs the number of levels, l, for each variable is 
always the same (for k = 3, l = 5 in a central composite design or l = 3 in a Box-Behnken 
design), while in the Doehlert design the first variable is studied at five levels, the second 
one at seven levels and the third one at three levels.  This allows us to select the order of 
the variables, studying the most critical ones at five and seven levels, and considering only 
three levels for the less critical ones
[116-118]
. 
We used the Doehlert design in order to study simultaneously the effect of the 
concentration of TEA, TBAB and 9-CMA on the derivatization reaction of a 0.4 mM 
lactate standard solution.  9-CMA and TBAB play an important role on the reaction as 
explained above.  The TEA concentration is an important parameter as well, since the 
analysis carried out using the HPLC-ESI-Q-ToF showed that TEA reacts with 9-CMA (see 
Chapter 4). 
The number of experiments required is thirteen, but fifteen experiments were carried out in 
order to assure the validity of the model by analyzing in triplicate the center point of the 
experimental domain.  For each experiment the lactate derivative peak area in the 
fluorescence chromatogram (λex = 365 nm, λem = 410 nm) was considered as response.  
Table 3.4 reports the fifteen experiments carried out with the corresponding response 
expressed as area of the lactate derivative peak in the fluorescence chromatogram            
(λex = 365 nm, λem = 410 nm) and Figure 3.13 shows the experimental domain.  
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Table 3.4: experiments performed for the Doehlert design (the coded values are reported in parentheses) 
 
Exp. 
N° 
x1 (TEA) 
mM 
x2 (TBAB) 
mM 
x3 (9-CMA) 
mM 
Peak area 
410 nm 
1 5.4 (0) 8.8 (0) 4.1 (0) 651466 
2 5.4 (0) 3.7 (-0577) 0.8 (-0.816) 272436 
3 10.8 (1) 8.8 (0) 4.1 (0) 757142 
4 5.4 (0) 13.9 (0.289) 7.4 (0.816) 870157 
5 0 (-1) 8.8 (0) 4.1 (0) 0 
6 2.7 (-0.5) 1.2 (-0.866) 4.1 (0) 218665 
7 8.1 (0.5) 1.2 (-0.866) 4.1 (0) 363961 
8 8.1 (0.5) 6.3 (-0.289) 7.4 (0.816) 734358 
9 2.7 (-0.5) 6.3 (-0.289) 7.4 (0.816) 444089 
10 2.7 (-0.5) 11.3 (0.289) 0.8 (-0.816) 331878 
11 8.1 (0.5) 11.3 (0.289) 0.8 (-0.816) 463244 
12 8.1 (0.5) 16.4 (0.866) 4.1 (0) 910655 
13 2.7 (-0.5) 16.4 (0.866) 4.1 (0) 664949 
14 5.4 (0) 8.8 (0) 4.1 (0) 661162 
15 5.4 (0) 8.8 (0) 4.1 (0) 664355 
 
 
Figure 3.13: 3D view of the experimental domain 
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By applying multiple regression analysis on the experimental data, the following second 
order polynomial equation was obtained: 
 
                                                    
                                                  
                                                 
                
 
The response function contains three linear, three quadratic, and three interaction terms and 
one block term.  
The model was validated by comparing the predicted value in the central point of the 
experimental design with the experimental value, which resulted not significantly different 
at 95% confidence.  
The significance of the obtained coefficient was determined by Student’s t-test: the larger 
the magnitude of the calculated t-value, the more significant is the corresponding 
coefficient
[119, 120]
.  
Table 3.5 summarizes the calculated coefficients of the model and the corresponding           
t-values. 
 
Table 3.5: calculated coefficients of the model and the corresponding t-values; the terms refer to the coded 
concentrations (mM) of the variables 
 
Term Coefficient Value t-value 
Constant b0 = 6.6·10
5 12.6 
[TEA] b1 = 2.9·10
5
 6.40 
[TBAB] b2 = 2.7·10
5
 6.02 
[9-CMA] b3 = 2.0·10
5
 4.41 
[TEA]x[TEA] b11 = -2.8·10
5
 -3.39 
[TBAB]x[TBAB] b22 = -7·10
4
 -0.79 
[9-CMA]x[9-CMA] b33 = -1.2·10
5
 -1.56 
[TEA]x[TBAB] b12 = 6·10
4
 0.55 
[TEA]x[9-CMA] b13 = 1.2·10
5
 1.01 
[TBAB]x[9-CMA] b23 = 3·10
4
 0.29 
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The values show that the more significant terms are the constant, the three linear and the 
first quadratic terms; while the less significant are the interaction terms between TEA and 
TBAB and between TBAB and 9-CMA. 
Figure 3.14 shows the correlation plot between the predicted and the experimental values 
(R
2
 = 0.972). 
 
Fig. 3.14: correlation plot between the experimental and the predicted values 
 
Figure 3.15 A), B) and C) shows the response surfaces obtained by plotting the area of the 
lactate peaks of the fluorescence chromatograms (λex = 365 nm, λem = 410 nm) as a 
function of TEA and 9-CMA concentration, TBAB and 9-CMA concentration and TEA 
and TBAB concentration, respectively.   
The response surfaces were obtained with Origin by converting the raw data into a 
100x100 matrix using a Random (Renka Cline) gridding method.   
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Fig. 3.15: response surfaces obtained from the experimental design (factors: TEA, TBAB and 9-CMA 
concentration) of a 0.04 mM lactate standard solution (injected concentration) as a function of (A) TEA and 
9-CMA concentrations, (B) TBAB and 9-CMA concentrations and (C) TEA and TBAB concentrations.  
Chromatographic conditions: Gemini C18 (250x4.6mm, 5μm, Phenomenex), isocratic elution with 65% 
ACN, 35% water 
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The results indicate that the signal increases as the TBAB and 9-CMA concentration 
increase.  The TBAB concentration affects the reaction between lactate and 9-CMA and 
the maximum signal is achieved when the highest TBAB concentration is used.  The 
optimal TEA concentration was found to be between 4.5 and 7.5 mM: higher TEA 
concentrations produce a 10% decrease of the signal because TEA reacts with 9-CMA (see 
Chapter 4).  
 
 
3.4. Optimization of the chromatographic conditions 
 
Once optimized the reaction conditions for lactate, the chromatographic and detection 
conditions were also optimized.  
 
 
3.4.1.  HPLC column 
 
Four different HPLC columns were tested in order to achieve the best separation of the 
lactate derivative with respect to the 9-CMA excess: 
 
 Synergi-Hydro RP-C18 (250 x 4.6mm, 5μm), Phenomenex 
Polar end-capped C18 phase, extreme hydrophobic and slight polar selectivity 
 
 Poroshell 120 EC-C18 (100 x 4.6mm, 2.7μm), Agilent 
End-capped C18 stationary phase chemically bonded to the porous shell of the     
1.7 μm silica support, maximum deactivation of the silica surface 
 
 MOS-2 Hypersil (250 x 2.1mm, 5μm), Thermo Scientific 
Not end-capped C8 phase, similar selectivity to C18 but less retentive 
 
 Gemini C18 (250 x 4.6mm, 5μm), Phenomenex 
Non polar end-capped C18 phase, rugger than Synergi-Hydro, extended lifetime 
under extreme pH conditions. 
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Table 3.6 summarizes the characteristics of the columns employed for the determination of 
lactate
[121-124]
. 
 
 
Table 3.6: characteristics of the columns employed for the determination of lactate.  Isocratic elution with 
50% ACN-50% water, column temperature set at 30 °C 
 
Parameter 
Synergi-
Hydro 
Poroshell 
MOS-2-
Hypersil 
Gemini 
Particle size 5 μm 2.7 μm 5 μm 5 μm 
Pore size 100 Ȧ 120 Ȧ 120 Ȧ 110 Ȧ 
Carbon load 19% 8% 6.5% 6.5% 
pH Range 1.5-7.5 2-8 2-8 2-8 
     
tR lactate
a 
8.7 ± 0.5 7.0 ± 0.2 4.8 ± 0.1 20.05 ± 0.09 
Theoretical plates
b 
14268 10244 10124 13806 
Retention factor
c 
2.71 4.08 4.09 7.77 
 
a)
 expressed as average ± confidence range at 95% (n = 6) 
b)
 calculated by N = 5.54*(tR/ω1/2) 
2
 where ω1/2 is the width at half height of the peak 
c)
 calculated as K = (tR-t0)/t0 
 
Figure 3.16 shows the typical absorbance chromatograms at 365 nm of 0.01 mM lactate 
standard solution (injected concentration) in the four tested RP columns. 
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D) 
 
 
Figure 3.16:  typical absorbance chromatograms at 365 nm of 0.01 mM lactate standard solution (injected 
concentration) in the four tested RP columns. A) Syergi-Hydro B) Poroshell, C) MOS-2-Hypersil, D) Gemini. 
Isocratic elution with 50% ACN-50% water, column temperature set at 30 °C 
 
Gemini RP column gave the best chromatographic, reproducible separation of lactate 
derivative with respect to the 9-CMA peaks. 
 
 
3.4.2. Mobile phase composition 
 
The mobile phase composition in Gemini RP column was optimized by changing the 
percentage of ACN from 40 to 65% in order to separate the lactate derivative peak from 
the interfering peak present in the blank solution.  Figure 3.17 shows the fluorescence 
chromatograms (λex = 365 nm, λem = 410 nm) of two representative isocratic elution 
conditions obtained with 45 and 65% ACN. 
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Fig. 3.17: fluorescence chromatograms at 410 nm (λex = 365 nm)  of 0.01 mM lactate standard solution 
(injected concentration) derivatized with 9-CMA using 45% (A) and 65% (B) ACN in the mobile phase 
 
The optimal condition was achieved using 65% of ACN.  This mobile phase composition 
provided a good separation between the two peaks and a very short time of analysis 
(lactate derivative tR= 8.73 min).  
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Furthermore, these experiments showed the dependence of the fluorescence quantum yield 
on the composition of mobile phase.  A significant quenching of fluorescence was 
observed as the concentration of water increases, according to Korte et al.
[115]
. 
Hence the using of 65% ACN in the mobile phase gave also an enhancement of the 
fluorescence response of about 30%.   
 
 
 
3.4.3. Fluorescence and absorbance detection 
 
 
The influence of the excitation wavelength on the fluorescence detection of the lactate 
derivative was investigated.  As the UV spectrum of 9-CMA has two characteristic 
absorptions at 256 and 365 nm (Figure 3.2 (A), Paragraph 3.1), both these wavelengths 
can be used as excitation frequencies.  The excitation at 256 nm leads to a higher 
sensitivity, but it is a unspecific wavelength because many compounds in biological 
matrices absorb at this wavelength.  Figure 3.18 shows a comparison of the fluorescence 
chromatograms at 410 nm of derivatized lactate standard solutions obtained by exciting at 
256 nm and at 365 nm. 
 
  
Fig. 3.18: fluorescence chromatograms at 410 nm (λex = 365 nm) of  lactate standard solutions derivatized 
with 9-CMA, obtained exciting at 256 nm (black line, 0.02 mM lactate injected concentration) and at 365 nm 
(red line, 0.2 mM lactate injected concentration). Chromatographic conditions: Synergi-Hydro RP-C18 
(250x4.6mm, 5μm, Phenomenex), isocratic elution with 64% ACN, 36% Milli-Q water 
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The excitation at 365 nm was selected in order to guarantee the best selectivity.  
The determination of lactate can be achieved even with the Diode Array Detector (DAD) 
monitoring the absorbance at 365 nm.  
Table 3.7 summarizes the optimal operating conditions for the derivatization and 
chromatographic determination of lactate. 
 
Table 3.7: summary of the optimal operating conditions for the derivatization and chromatographic 
determination of lactate 
 
Derivatization conditions 
Reaction temperature 70 °C 
Reaction time 0.5 h 
[9-CMA] 7.4 mM 
[TBAB] 16.2 mM 
[TEA] 10.8mM 
Chromatographic and detection conditions 
HPLC RP-Column Gemini 
Mobile phase isocratic 65% ACN 
DAD 365 nm 
FD λem = 410 nm, λex = 365 nm 
 
 
 
3.5.  Simultaneous determination of lactate and 
creatinine 
 
In the case of urine samples the determination of lactate requires a normalization of lactate 
level with respect to the amount of urinary creatinine in order to compare the results from 
different samples.  Clinical determination of urinary creatinine, as explained in Paragraph 
1.5.3., is in general performed by the colorimetric determination of creatinine (Jaffé 
method).  This represents, in fact, a great inconvenience in terms of costs and time of the 
analysis.  
Thus, we optimized the simultaneous determination of both lactate and creatinine in our 
experimental conditions.  
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3.5.1. Chromatographic determination of creatinine 
 
Several authors proposed the simultaneous determination of creatinine and other analytes 
in urine samples by HPLC-DAD
[108, 109, 125, 126]
.  Creatinine has, indeed, a characteristic 
absorption at 234 nm (Figure 3.19) and elutes in a RP column typically with high 
percentages of water in the mobile phase
[109, 126]
. 
 
 
 
Fig. 3.19: UV-Vis spectrum of creatinine 
 
 
 
Figure 3.20 shows a representative absorbance chromatogram at 234 nm of 0.3 mM 
creatinine aqueous solution analyzed by our system with an isocratic elution 1% ACN-99% 
water.  Creatinine elutes at 5.45 min. 
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Fig. 3.20: representative absorbance chromatogram at 234 nm of 0.3 mM creatinine aqueous solution.  
Chromatographic conditions: Gemini C18 (250x4.6mm, 5μm, Phenomenex), isocratic elution with             
1% ACN-99% water 
 
Figure 3.21 shows the calibration plot of creatinine analyzed in the above described 
conditions, which is linear over 4 order of magnitude (10
-4
 – 10-1 mM). 
 
 
Fig. 3.21: creatinine calibration plot obtained by plotting the chromatographic peak area as a function of 
creatinine concentration 
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3.5.2. Optimization of the chromatographic conditions for the 
simultaneous determination of lactate and creatinine 
 
A standard solution of creatinine was added to the reaction vial in order to check if our 
derivatization procedure affects the creatinine detection. 
In our optimized conditions (65% ACN, see Table 3.5, Paragraph 3.4.4) creatinine elutes 
just after the dead volume of the column and coelutes with an anthracene derivative peak.  
Thus, ACN percentage was reduced to 20% to get a good separation between the two 
peaks (Figure 3.22 ). 
 
 
Fig. 3.22: absorbance chromatogram at 234 nm of a 0.02 mM creatinine standard solution (injected 
concentration) after the lactate derivatization procedure.  Chromatographic conditions: Gemini C18 
(250x4.6mm, 5μm, Phenomenex),  isocratic elution with 20% ACN -80% water 
 
Thus, the optimized chromatographic conditions reported in Table 3.7 (Paragraph 3.4.4) 
were modified in order to obtain the simultaneous determination of creatinine and lactate 
derivative, as reported in Table 3.8.  This method was adopted for the analysis of urine 
samples. 
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Table 3.8: summary of the optimal operating conditions for the derivatization and the simultaneous 
chromatographic determination of lactate and creatinine 
 
Derivatization conditions 
Reaction temperature 70 °C 
Reaction time 0.5 h 
[9-CMA] 7.4 mM 
[TBAB] 16.2 mM 
[TEA] 10.8 mM 
Chromatographic and detection conditions 
HPLC RP-Column Gemini 
Mobile phase gradient from 20 % to 65% ACN 
DAD 
365 nm (lactate derivative) 
234 nm (creatinine) 
FD λem = 410 nm, λex = 365 nm 
 
Figure 3.23 shows the calibration curve of creatinine obtained by adding the calibration 
solutions to a reaction medium containing all the reagents employed and adopting the same 
procedure for the lactate derivatization.   
 
 
Fig. 3.23: creatinine calibration plot obtained by plotting the chromatographic peak area as a function of 
creatinine concentration 
 
The slope of the calibration curve was (4.1±0.3)·10
7 
(R
2
=0.999), corresponding to 89% of 
the slope of calibration curve obtained in water.   
Detection and quantification limits were 0.00009 and 0.0003 mM respectively, calculated 
as 3 and 10 times the standard deviation of the blank divided for the calibration curve 
slope. 
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Table 3.9 summarizes the intra-day and inter-day repeatability evaluated at three different 
concentration levels of creatinine (see Paragraph 2.1.1). 
 
 
Table 3.9: intra-day and inter-day repeatability for three concentration levels of creatinine 
 
Concentration level/mM Intra-day
a
 
 
Inter-day
a
 
 
LQC (0.0003) 7% 8% 
MQC (0.001) 2% 7% 
HQC (0.01) 1% 6% 
 
a
 expressed as RSD%, n = 3 (intra-day), n = 9 (inter-day) 
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3.6.  Analytical figures of merit 
 
3.6.1. Linearity, repeatability and detection limits 
 
Calibration was performed on the lactate derivative.  Standard solutions covering the 
concentration ranges 0.0001-0.03 mM (injected concentrations) were employed as 
calibration samples.  These solutions were prepared by diluting the corresponding stock 
solution with Milli-Q water.  A new calibration was carried out monthly when a new stock 
solution of 9-CMA was prepared.  The calibration curves were reproducible over 5 months 
giving a slope of (3.3 ± 0.1)·10
7
 (R
2 
= 1.000).  A control standard solution (MQC) was 
analyzed in each set of experiments in order to correct the concentrations of the samples 
analyzed. 
The quality control standard solutions (see Paragraph 2.1.1) were analyzed in triplicate 
every day for three days in order to evaluate the intra-day and inter-day repeatability.  
Calibration curves for the lactate derivative were obtained by linear regression analysis of 
the peak area plotted against the nominal analyte concentration. 
Figure 3.24 shows the calibration curve of lactate. 
Table 3.10 shows the method validation parameters for the determination of lactate. 
 
 
 
Fig. 3.24: lactate calibration plot obtained by plotting the peak area of the fluorescence chromatogram (λex = 
365 nm, λem = 410 nm) as a function of lactate concentration 
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Table 3.10:  method validation parameters 
 
Parameter Lactate 
 410 nm 365 nm 
Linearity   
Range (mM) 0.0002-0.03 0.0002-0.03 
Slope
a 
(3.3±0.1)·10
7 
(4.4±0.3)·10
7
 
R
2 
1.000 0.998 
Intra-day repeatability
b   
LQC (0.0003 mM) 5% 5% 
MQC (0.001 mM) 2% 1% 
HQC (0.01 mM) 3% 1% 
Inter-day repeatability
b   
LQC (0.0003 mM) 5% 6% 
MQC (0.001 mM) 6% 4% 
HQC (0.01 mM) 5% 3% 
   
LOD (mM)
c 0.00005 0.00006 
LOQ (mM)
d 0.0002 0.0002 
 
a 
95% confidence interval (n = 7) 
b
 expressed as RSD%, n = 3 (intra-day), n = 9 (inter-day) 
c
 calculated as 3 times the standard deviation of the blank divided by the calibration curve slope 
d 
calculated as 10 times the standard deviation of the black divided by the calibration curve slope 
  
 
3.6.2. Selectivity and stability 
 
The selectivity of the method was assessed by derivatizing several organic acids that can 
be found in the biological matrices analyzed, i.e. proprionic, acetic, butyric and pyruvic 
acids.  Only the pyruvate derivative formation was observed but it does not represent an 
interference for the determination of lactate because it elutes before the 9-CMA peak. 
 
The lactate derivative was found to be stable for 24 hours at 4 °C.  Fifteen days after 
preparation we observed an increase of the peak area by about 50% likely because of the 
formation of interfering compounds.  
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CHAPTER 4 
 
Characterization of the 
derivatization products by 
HPLC-ESI-Q-ToF 
 
LC-MS/MS is a useful technique that provides information about the molecular weight and 
the structure of analytes.  
In this work we employed an HPLC-ESI-Q-ToF instrument in order to confirm the 
formation of the lactate derivative (by the reaction between lactate and 9-CMA) and to 
investigate on the by-products of the reaction.  
The electrospray ionization (ESI) is a soft ionization technique that occurs on a spray, 
which is produced by forcing the eluent flow from the liquid chromatographic system to 
pass through a capillary.  An electric field (2.5-4 kV) is applied to the capillary and it 
causes ionization.  Figure 4.1 shows the ESI ionization process. 
 
 
Fig. 4.1: schematic representation of the ESI ionization process 
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The main feature of the ESI spectrum is the presence of protonated ([M+H]
+
, in positive 
mode) or deprotonated ([M-H]
-
, in negative mode) molecules, ionic adducts ([M+Na]
+
 and 
[M+K]
+
 in positive mode, and [M+HCOO]
-
 in negative mode) and multiply charged ions. 
The MS/MS experiment provides the fragmentation (by the collision with nitrogen in the 
collision cell) of a specific ion (selected with the first quadrupole).  The Time of Flight 
analyzer provides the scanning of the fragments.  
Figure 4.2 shows the mass spectrometry system. 
 
 
 
Fig. 4.2: mass spectrometry system 
 
 
4.1. Proof of the lactate derivative formation 
 
The first analyses were carried out employing the same HPLC column used for the analysis 
by HPLC-DAD/FD (Gemini C18) in order to assure the selectivity of the method.  The 
elution method was suitably modified since the maximum flow rate of the eluent, required 
for an adequate ionization, is 0.4 mL/min (see Table 2.2 A), Paragraph 2.4).  The same 
flow rate was employed in the HPLC-DAD/FD analysis of 0.002 mM lactate standard 
solution (injected concentration) and a blank solution in order to identify uniquely the 
lactate peak.  The time acquisition segments and the scan source parameters are 
summarized in Table 2.3 B) and C), Paragraph 2.4. 
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Figure 4.3 A) and B) shows a representative TIC and absorbance (365 nm) chromatograms 
of a lactate standard solution derivatized with 9-CMA and analyzed by HPLC-ESI-Q-ToF 
and HPLC-DAD/FD, respectively. 
The chromatographic profile was the same using the two systems, showing the two peaks 
at tR = 29.54 and tR = 30.88 min, characteristic of aqueous lactate standard solution 
derivatized with 9-CMA.  The Find by Formula command of the software attributes the 
peak at 30.88 min to the lactate derivative (85% match).  Figure 4.4 A) and B) shows the 
mass spectrum of the peak at 30.88 min and the peak attribution to the lactate derivative, 
respectively.  
 
A) 
 
B)
 
Fig. 4.3: chromatographic profile of a lactate standard solution and a black derivatized with 9-CMA and 
analyzed by HPLC-ESI-Q-ToF (A) and HPLC-FD (B). INLET: zoomin between 25 and 37 min 
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A) 
 
B) 
 
Fig. 4.4: A) mass spectrum corresponding to the lactate derivative peak (tR = 30.8 min), B) peaks attribution 
 
The main m/z in the peak spectrum is 191.086, which corresponds to the anthrylmethyl 
cation resulting from the loss of lactate
[127]
.  Moreover, it is possible to identify the adduct 
ions of the lactate derivative with K
+
 (m/z 319.074), with Na
+
 (m/z 303.100) and with H
+
 
(m/z 281.122).  Although the software attributed the mass 281.122 to the lactate derivative, 
this mass belongs to the isotopic cluster of the mass 280.122, which corresponds to the 
exact mass of the [M]
•+
 ion (see Paragraph 4.3 in this chapter for further discussion). 
The comparison between the extract-ion chromatograms at 191 m/z of a lactate standard 
solution and a blank derivatized with 9-CMA, allowed us to unambiguously identify the 
lactate derivative and the 9-OHMA (Figure 4.5). The 9-OHMA is not formed if lactate is 
not present in the reaction medium. 
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Fig. 4.5: extract-ion chromatograms at 191 m/z of a 0.005 mM lactate standard solution (injected 
concentration) and of a blank 
 
 
In these conditions the creatinine elutes at 5.39 min.  Figure 4.6 A) and B) shows the 
extract-ion chromatogram at 114 m/z and the creatinine mass spectrum. 
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Fig. 4.6: extract-ion chromatogram at 114 m/z (A) and creatinine mass spectrum (B) 
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4.2. Characterization of the structures by MS 
interpretation 
 
The method was transferred to another HPLC column (Zorbax Extend C18 column, 2.1 
mm x 50 mm, 1.8 µm) with a Zorbax Extend C18 guard column (2.1 mm x 12.5 mm, 5 
µm)), in order to complete the chromatographic run in 10 min.  Although the Zorbax 
column is shorter, the reduced diameter and particle size allowed us to obtain a resolution 
comparable with that achieved with the previous set up.  Injection volumes were reduced 
accordingly. 
The mass spectrometer conditions were optimized in order to find the best ionization 
conditions.  The fragmentation of the anthracene derivatives leads to unspecific fragments 
(m/z 191.086), which do not provide any information about the structure of the parent ion. 
Thus, the fragmentor and capillary voltages were chosen in order to produce the highest 
abundance of the parent ions and a reduced fragmentation, resulting in a higher intensity of 
the analytes diagnostic masses ([M+Na]
+
 and [M+K]
+
). 
The interpretation of the mass spectra was based on the determination of the exact mass 
and thus of the raw formula of the analytes and on the interpretation of the fragmentation 
patterns. 
In particular, the peak at 4.44 min was attributed to 9-TEA-MA (Figure 4.7): m/z 340.191 
corresponds to the [M+H]
+
 pseudomolecular ion of 9-TEA-MA. The peak at 191.086 m/z 
is clearly visible in the spectrum. 
 
 
 
Fig. 4.7: mass spectrum of 9-TEA-MA (tR = 4.44 min) 
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Furthermore, the mass spectrum of the compound eluting at 5.46 min (Figure 4.8) shows a 
peak at m/z 231.078 and 247.058, corresponding the [M+Na]
+
 and [M+K]
+
 adducts of      
9-OHMA, respectively.  The anthrylmethyl fragment, m/z 191.086 m/z, is also clearly 
visible.  Interestingly, the pseudo-molecular ion [M+H]
+
 is not present in the mass 
spectrum of 9-OHMA.  Similarly to the lactate derivative, a peak corresponding to the 
exact mass of [M]
•+
 is present.  
 
 
Figure 4.8: mass spectrum of 9-OHMA (tR = 5.46) 
 
The unambiguous identification of the 9-CMA peak was not possible due to its complete 
fragmentation in the source. 
 
Table 4.1 summarizes the peaks attribution on the basis of the mass spectra obtained in the 
optimized conditions (see Table 2.3, Paragraph 2.4.).  
 
Table 4.1: peaks attribution on the basis of the mass spectra obtained in the optimized conditions 
 
tR (min) Compound MW m/z 
0.50 Creatinine 113 136.057 [M+Na]
+
,
 
114.066 [M+H]
+
 
4.44 9-TEA-MA 339 
362.172 [M+Na]
+
,
 
340.191 [M+H]
+
, 
191.086 [M-TEA]
+
 
5.46 9-OHMA 208 
247.058 [M+K]
+
, 231.078 [M+Na]
+
, 
208.088 [M]
•+
, 191.086 [M-H2O]
+
 
5.85 Lactate derivative 280 
583.208 [2M+Na]
+
, 319.074 [M+K]
+
, 
303.084 [M+Na]
+
, 280.109 [M]
•+
, 191.086 
[M-C3H6O3]
+
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In conclusion, it was possible to positively identify the lactate derivative, and to assess the 
presence of the 9-OHMA.  Moreover, a product of the reaction between TEA and 9-CMA 
was determined.  This suggests that the concentration of the TEA is critical for the overall 
reaction of derivatization. 
The comparison between a standard solution of lactate and a blank proved that 9-OHMA is 
not formed if the analyte is absent.  Thus, 9-OHMA is the final product of the hydrolysis of 
lactate ester.  
 
 
4.3. The lactate derivative characterization  
 
The lactate derivative was characterized by target MS/MS experiments on the main masses 
of its mass spectrum.  In particular, the nature of the ions attributed to [M+H]
+
 and [M]
+• 
was investigated. 
The fragmentor potential was set at 70 V, instead of 100 V, in order to yield the maximum 
abundance of the pseudo-molecular ions, and the mass range was set at 85 – 600 m/z. 
Figure 4.9 shows the mass spectrum of the lactate derivative acquired in full scan. 
 
 
 
Fig. 4.9: mass spectrum of the lactate derivative obtained by setting the fragmentor potential at 70 V  
 
The intensity of the m/z 303.084, 319.074, 583.208 and 281.109 were found to be higher 
than the previous experiments.  As expected, a lower fragmentor potential induced a softer 
fragmentation of the lactate derivative, resulting in a higher intensity of the diagnostic 
masses and in the absence of the fragment 191.086.  
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As reported above, the m/z 303.084 and 319.074 correspond to the [M+Na]
+
 and [M+K]
+
 
adducts, respectively.  The attribution of the other m/z peaks was based on MS/MS 
experiments.  Figure 4.10 A), B) and C) shows the target MS/MS spectra of the m/z 583.2, 
280.1 and 281.1, respectively.  
 
A) 
 
B) 
 
C) 
 
Fig. 4.10: target MS/MS spectra of m/z 583.2 (A), 280.1 (B) and 281.1 (C) 
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The MS/MS spectrum of the m/z 583.2 (Figure 4.10 A) confirmed that this ion corresponds 
to the dimer of the Na
+ 
adduct of the lactate derivative due to the presence of the m/z 
303.097 ([M+Na]
+
 of the lactate derivative) and 191.084 (anthrylmethyl cation). 
The MS/MS spectrum of the m/z 280.1 (Figure 4.10 B) only contains the ion 
corresponding to the anthrylmethyl cation (m/z 191.084).  It is important to notice that only 
one isotope of the anthrylmethyl cation is detected.  On the contrary, the MS/MS spectrum 
of the m/z 281.1 (Figure 4.10 C) shows both the isotopes at 191.084 and 192.085 of the 
anthrylmethyl cation, confirming that this ion belongs to the isotopic cluster of m/z 
280.108. 
 
Thus, the mass spectrum of lactate derivative does not show the ion corresponding to 
[M+H]
+
. Only a m/z corresponding to [M]
•+
 was identified. 
 
The mobile phase was modified by adding 1% of formic acid in order to increase the 
protonation of the molecules during the ionization in the ESI source. 
An increase of the intensity of all the masses in the mass spectrum of the lactate derivative 
was observed. Thus, another MS/MS experiment on the m/z 280.1 was carried out.  
Figure 4.11 shows the corresponding MS/MS spectrum. 
 
 
Fig. 4.11: target MS/MS spectrum of m/z 280.1 
 
In the MS/MS spectrum the presence of the m/z 91 (corresponding to protonated lactic 
acid) confirms that the m/z 280.109 contains the lactate.  It has to be stressed that for m/z 
lower than 100, the resolution of the mass spectrometer is lower than for higher masses. 
This result confirm our attribution of the m/z 280.109 to the [M]
•+ 
of the lactate 
derivative
[127]
. 
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CHAPTER 5 
 
Application to urine samples 
 
Urine contains more than 95% water and its physical properties and chemical composition 
are highly variable because they depend on diet, metabolism and body mass.   
Tables 5.1, 5.2 and 5.3 summarizes the amounts of the most abundant compounds 
(inorganic, nitrogen and non-nitrogen compounds respectively) excreted in the urine of 
healthy people per day (the average urinary flow is 690-2690 mL/d)
[128]
. 
 
Table 5.1: concentrations of the most abundant inorganic compounds 
 
Compounds Concentration Units 
Chloride
 
80-270 mmol/d 
Phosphate
 
26-65 mmol/d 
S total 39-47 mmol/d 
Thiocyanate 0-0.10 mmol/d 
Fluoride 0.047-0.153 mmol/d 
Bromide 0.020-0.084 mmol/d 
Potassium 40-100 mmol/d 
Sodium 80-560 mmol/d 
Calcium < 10 mmol/d 
Magnesium 2.5-8.3 mmol/d 
Iron 0.0009-0.0063 mmol/d 
Copper 0.0002-0.0018 mmol/d 
Zinc 0.0021-0.0182 mmol/d 
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Table 5.2: concentrations of the most abundant nitrogen compounds 
 
Compounds Concentration Units 
Urea 343 mmol/d 
Creatine 0.14-2.06 mmol/d 
Creatinine 0.35-8.8 mmol/d 
Uric acid 3.14 mmol/d 
Methyl-guanidine 0.008-0.040 mmol/d 
Guanidine acetic acid 0.235 mmol/d 
Ammonia 42 mmol/d 
α-amino nitrogen 30 mmol/d 
Carnitine 0.358 mmol/d 
Acetonitrile 0-0.003 mmol/d 
Piperidine 0.055-0.083 mmol/d 
p-tiramine 0.0036-0.012 mmol/d 
 
 
Table 5.3: concentrations of the most abundant non-nitrogen compounds 
 
Compounds Concentration Units 
Glucose 0-1 mmol/d 
Lactose 0.01-0.05 mmol/d 
Glucoronic acid 2.22 mmol/d 
Formic acid 0.04-0.73 mmol/d 
Acetic acid 0.11-3.7 mmol/d 
Isobutyric acid 9-122 mmol/mol 
Glycolic acid 0.24-0.80 mmol/d 
Oxalic acid 0.2-0.5 mmol/d 
Lactic acid 0.1-1.7 mmol/d 
Pyruvic acid 0.06-0.13 mmol/d 
Citric acid 0.21-6.35 mmol/d 
Acetaldehyde 1-660 µmol/L 
Acetone 3-43 µmol/L 
Phenol 0.085-0.140 mmol/d 
Pheylacetic acid 0.46-2.7 mmol/d 
Ascorbic acid 0.162 mmol/L 
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The optimized method was applied to the determination of lactate in urine samples.   
In particular, two kinds of samples have been analysed: 
 
1. Urine from healthy volunteers before and after a training session; 
2.  Urine from patients from the intensive care unit of Cisanello Hospital (Pisa). 
 
The use of urine samples to monitor the athletes during training allows to find the average 
lactate concentration accumulated during the training, because the samples were collected 
before and after the training.  The comparison of the lactate content before and after 
training provides information about the endurance leading to find the best and personalized 
type of training for each athlete.  The increase in lactate concentrations depends, indeed, on 
the type of training but also on the physical conditions and endurance of the athlete.  For 
example a strong training is required to produce an increase in lactate concentration in 
well-trained athletes, while a soft training is enough for an untrained athletes.  
Since a comparison of two samples (before and after training) is required, the dilution of 
the urine samples plays a crucial role in these type of analysis.  In fact the urinary 
concentration of metabolites is strictly dependent on the amount of water consumed by the 
subject.  Hence the absolute concentration values are meaningless. 
Our method, which allows the simultaneous determination of lactate and creatinine, 
overcomes this problem because it allows the normalization of the absolute lactate 
concentration with respect to the urinary creatinine content.   
 
The excretion rate of lactate in urine has been poorly studied and reported in only two 
published papers.  Liljestrand and Wilson have made the most complete study of urinary 
lactate excretion
[129]
.  They obtained samples of urine every 10 minutes from their subjects 
and constructed a complete curve for rates of excretion during recovery.  They found that 
the urinary lactate reaches the maximum value 10 min after the completion of the exercise 
and disappears after 50 min.  For this reason the urine samples analyzed in this work were 
collected by 30 min the end of the exercise.  
 
The study of the urine samples of the patients from the intensive care unit was carried out 
to find an eventual correlation between the urinary lactate concentration and the lactemia 
in order to understand if the urinary lactate concentration can be employed as a prognostic 
marker of a respiratory failure.  
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The physical conditions of these patients are constantly monitored in term of pO2, pCO2, 
[Na
+
], [K
+
], glicemia, lactemia, etc. and is performed every hour on the arterial blood. 
Urine samples were collected for 1 h after the measure of lactemia.  The normalization of 
the lactate concentration for the creatinine content was found to be useless because in 
many cases the renal function of these patients was compromised.  For this reason the 
lactemia values were compared with the absolute concentration values of the urinary 
lactate.  However, the comparison of the absolute lactate concentration between the 
different samples is meaningful because these patients were bedridden and the daily water 
intake is almost constant.  
 
 
5.1. Improvements of the method for the application in urine 
samples 
 
A further optimization of the method was required for its application to urine samples.  
This biological matrix is very complex due to the presence of many endogenous 
compounds which may affect the selectivity.  
Figure 5.1 shows the fluorescence chromatogram (λex = 365 nm, λem = 410 nm) of a 
representative urine sample obtained in our optimized conditions (Table 3.8, Paragraph 
3.5.2.) where it results that an interfering compound elutes at 16.20 min, close to the lactate 
derivative (tR = 16.01 min). 
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Fig. 5.1: fluorescence chromatogram at 410 nm (λex = 365 nm) of a urine sample derivatized with 9-CMA.  
INLET: zooming between 15 and 18 min of the endogenous lactate peak. 
Chromatographic conditions: Gemini C18 (250x4.6mm, 5μm, Phenomenex), elution method 1 (see Table 2.1 
B), Paragraph 2.3.) 
 
To overcome this problem we tried to increase the column temperature to improve the 
chromatographic resolution.  The best chromatographic resolution was achieved by 
thermostating the column at 40°C. 
 
 
5.2. Dilution of the samples and matrix effect 
 
The presence of proteins may affect the HPLC analysis because they can precipitate in the 
column.  In general, the protein content in urine of healthy people is very low, but it 
increases in case of infection or other pathologies.  In order to overcome this problem a 
deproteinization step or a high dilution of the samples is required.  We decided to dilute the 
samples not only to preserve the column but also to reduce the matrix effect and to increase 
the 9-CMA excess available for the lactate derivatization.   
Figure 5.2 shows a representative fluorescence chromatogram of a post training urine 
sample (A), and  a 3D absorbance chromatogram of the same urine sample (B).  
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A) 
 
B) 
 
 
Fig. 5.2: (A) fluorescence chromatogram at 410 nm (λex = 365 nm) of a post training urine sample derivatized 
with 9-CMA.; (B) 3D absorbance chromatogram of the same urine sample. 
Chromatographic conditions: Gemini C18 (250x4.6mm, 5μm, Phenomenex), elution method 1 (see Table 2.1 
B), Paragraph 2.3), column temperature 40 °C 
 
Figure 5.2 (B) shows numerous peaks with the characteristic UV-Vis absorption spectrum 
of 9-CMA, indicating that 9-CMA reacts with many endogenous compounds. 
The analytical addition method was applied to urine samples to study the matrix effect.  
Furthermore, the effect of 9-CMA concentration was also evaluated. 
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Two levels of urine dilution were used and for each dilution level, 3 different 
concentrations of 9-CMA were employed.  In each case the analytical addition method was 
carried out.  Table 5.4 summarizes the slope values of the calibration curves found in each 
experiment obtained by plotting the area of lactate derivative in the fluorescence 
chromatogram (λex = 365 nm, λem = 410 nm) as a function of lactate concentration added. 
 
Table 5.4: slope values found in the analytical addition methods 
 
DILUTION 1:10 DILUTION 1:25 
[9-CMA]/mM slope [9-CMA]/mM slope 
0.4 5.7 E+05 0.4 2.8 E+06 
4 5.7 E+06 3 1.0 E+07 
6.4 6.8 E+06 7.4 1.3 E+07 
 
Figure 5.3 shows the trends of the slope reported above as a function of 9-CMA 
concentration.  The dotted line indicates the slope value of the external calibration curve. 
 
 
Fig. 5.3: trends of the slope reported above as a function of 9-CMA concentration 
 
The slopes increase as 9-CMA concentration increases and for the highest dilution level. 
However a significant matrix effect on both the dilution levels was observed.  This matrix 
effect does not depend on the 9-CMA excess because for both the dilution levels a plateau 
is reached for 9-CMA concentration higher than 4 and 3 mM for 1:10 and 1:25 dilution 
levels, respectively.  
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The slope of the analytical addition methods carried out on urine samples diluted 50 times 
with the maximum 9-CMA concentration (7.4 mM), was 70% of the external calibration 
curve slope (2.3·10
7
 vs. 3.3·10
7
 for fluorescence detection and 3.1·10
7
 vs. 4.5·10
7
 for UV 
detection).  Higher dilution does not provide a significant increase in the analytical 
addition method curve slope.  Thus, urine samples were diluted 50 times. 
The matrix effect was studied on 4 different urine samples from healthy volunteers 
containing different creatinine concentration, which reflects a different dilution level. 
Table 5.5 shows the slopes of the calibration curves obtained from the analytical addition 
method carried out on the four different samples. 
 
Table 5.5: slopes of the calibration curves obtained from the analytical addition method carried out on four 
different samples containing different creatinine concentrations 
 
Sample Slope (410 nm) Slope (365 nm) Creatinine (mM) 
1 
(2.17 ± 0.03)·10
7
  
R
2
 = 1.000 
(3.14 ± 0.03)·10
7
 
R
2
 = 1.000 
8.5 
2 
(2.28 ± 0.05)·10
7 
R
2
 = 1.000 
(3.30 ± 0.04)·10
7 
R
2
 = 1.000 
27 
3 
(2.34 ± 0.04)·10
7
 
R
2
 = 0.998 
(3.06 ± 0.06)·10
7
 
R
2
 = 0.998 
15 
4 
(2.27 ± 0.04)·10
7
 
(R
2
 = 0.998) 
(3.21 ± 0.05)·10
7
 
R
2
 = 0.999 
11.5 
 
All the slope values are expressed as the average ± the standard deviation (n = 2) 
 
Although the t-test has a low reliability because of the low number of replicates, the slope 
values were not significantly different (t-test, 95% confidence, n=2).  Hence the matrix 
effect, considering the 1:50 dilution of the samples, is independent of the creatinine 
concentration level.  
The analytical addition method was also carried out on a pooled urine sample (obtained by 
mixing ten different urine samples).  The slope values obtained were ((2.31 ± 0.03)·10
7
 for 
fluorescence detection and (3.20 ± 0.04)·10
7
 for UV detection) not significantly different 
from the average values calculated from data of Table 5.5. 
The 95% confidence interval (n = 5) was (2.3 ± 0.1)·10
7
 for the fluorescence detection and 
(3.2 ± 0.1)·10
7
 for the UV detection.  
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The matrix effect on the determination of creatinine was also investigated, carrying out the 
analytical addition method on several urine samples.  The average analytical addition 
method slope was found to be (4.4 ± 0.4)·10
7
 that is not significantly different (95% 
confidence level) from the slope of the external calibration curve, which indicates the 
absence of any matrix effect.  Therefore the creatinine concentration was calculated by 
using the external calibration curve.  
 
 
5.3. Analytical figures of merit 
 
Table 5.6 summarizes the fitting parameters of the analytical addition method curves 
obtained on the pooled urine sample. 
 
Table 5.6: fitting parameters of the analytical addition method curves obtained on the pooled urine sample 
for fluorescence detection at 410 nm (λex = 365 nm) and UV detection at 365 nm 
 
Parameter 410 nm 365 nm 
Slope (2.31 ± 0.03)·10
7 
(3.20 ± 0.04)·10
7
 
R
2
 0.999 0.999 
 
All the slope values are expressed as the average ± the standard deviation (n = 2) 
 
Repeatability and recovery were calculated in order to estimate the precision and the 
accuracy of the method.  Intra-day repeatability was calculated as the RSD% of the 
concentrations of lactate found in the urine sample as such and in the same urine sample 
with different spikes of a lactate standard solution (LQC, MQC and HQC).  Intra-day 
recoveries were calculated as the percentage ratio of the concentration of lactate in a spiked 
urine sample after subtraction of the endogenous lactate concentration, with respect to the 
nominal concentration of lactate added to the sample.  
Table 5.7 summarizes the intra-day repeatability and recoveries for three different spike 
levels in a pooled urine sample. 
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Table 5.7: intra-day repeatability and recoveries for three different spike levels in a pooled urine sample 
 
Lactate spike 410 nm 365 nm 
Intra-day repeatability   
0 4% 5% 
LQC (0.0003 mM) 3% 2% 
MQC (0.001 mM) 1% 4% 
HQC (0.01 mM) 2% 1% 
Intra-day recovery   
0 / / 
LQC (0.0003 mM) 92% 99% 
MQC (0.001 mM) 105% 106% 
HQC (0.01 mM) 94% 98% 
 
 
 
5.4. Urinary lactate before and after training 
 
Table 5.8 shows the lactate concentration before and after training for eleven healthy 
volunteers (the values are also expressed as mmol of lactate per mol of creatinine). 
 
 
Table 5.8: lactate concentration before and after training for eleven healthy volunteers (the values are also 
expressed as mmol of lactate per mol of creatinine; the 95% confidence interval is reported for each value,      
n  = 3) 
 
 BEFORE TRAINING AFTER TRAINING 
Sample Gender Age [lactate] / mM mmol/mol [lactate] / mM mmol/mol 
S.A. F 25 0.39 ± 0.05 42 ± 7 0.31 ± 0.02 13 ± 1 
V.D.P. 1 F 31 0.53 ± 0.01 19 ± 1 0.27 ± 0.02 10 ± 1 
A.B M 26 0.143 ± 0.007 51 ± 4 30.6 ± 0.8 1375 ± 165  
E.B. 1 F 45 < LOQ / 2.75 ± 0.05 530 ± 34 
P.D. M 25 0.15 ± 0.01 24 ± 2 20.9 ± 0.7 720 ± 92 
S.R. M 27 0.14 ± 0.02 8 ± 3 7.8 ± 0.3 4538 ± 251 
E.B. 2 F 45 < LOQ / 0.79 ± 0.05 37 ± 3 
I.D. F 27 0.094 ± 0.007 31 ± 2 1.04 ± 0.02 21 ± 1 
D.P. M 25 < LOQ / 0.22 ± 0.02 8 ± 1 
B.C. F 24 0.15 ± 0.02 22 ± 2 0.36 ± 0.04 92 ± 13 
V.D.P. 2 F 31 0.18 ± 0.02 13 ± 2 0.70 ± 0.08 33 ± 4 
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It is interesting to observe that the concentration of lactate in urine before training ranges 
between 0.09-0.18 mM (8-31 mmol/mol) in healthy people. Higher basal values are due to: 
 
 Diabetes (sample S.A.) 
 Concentrated urine (sample V.D.P. 1) 
 
The urinary lactate concentration after exercise is very different and depends on the type of 
training and on the personal endurance (as explained above).  The highest values were 
found in the samples from four subjects (A.B., S.R., P.D., E.B. 1) after intense work out.  
 
 
5.5. Urinary lactate and lactemia 
 
Table 5.9 summarizes the urinary lactate concentrations (determined by our optimized 
method, n = 3 replicates) and the lactemia values of six urine samples from patients of the 
intensive care unit of Cisanello Hospital (Pisa).   
 
 
Table 5.9: urinary lactate concentrations (determined by our optimized method; 95% confidence interval is 
indicated; n =  3) and the lactemia values of six urine samples from patients of the intensive care unit of 
Cisanello Hospital (Pisa) 
 
Sample Lactemia / mM Urinary lactate / mM 
G1 2.2 0.89 ± 0.02 
NS 4.3 4.8 ± 0.3 
SP1 2.1 0.86 ± 0.08 
D 1.8 0.18 ± 0.02 
SA 1.5 < LOQ 
M 0.9 < LOQ 
 
 
The results indicate that the optimized method allows the monitoring of the urinary lactate 
concentration.  Future studies will be carried out in order to find a correlation between 
urinary lactate and lactemia. 
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CHAPTER 6 
 
Application to saliva samples 
 
Saliva is a watery substance located in the mouth of organisms and secreted by salivary 
glands.  The two parotid glands are wrapped around the mandibular ramus and produce 
saliva to facilitate mastication and swallowing.  Most of the stimulated saliva comes from 
the parotid glands. 
The two submandibular glands are located beneath the lower jaws, superior the digastrics 
muscles and produce about the 70% of the saliva in the oral cavity.  There are also the 
sublingual and other minor glands which produce about the 10% of the total saliva.  
Salivary flow can be stimulated by drugs, as pilocarpine or by mastication.    
Figure 6.1 shows the salivary glands. 
 
 
Fig. 6.1: parotid (1), submandibular (2) and sublingual (3) glands 
 
 Human saliva is 99.5% water, while the other 0.5% consists of electrolytes, mucus, 
glycoproteins, enzymes and antibacterial compounds.  The salivary concentration of 
metabolites depends on the type of saliva collected, the way of stimulation, the period of 
the year and on the person (age, gender, diet, etc.). 
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Generally the average daily production of saliva is 500-1500 mL. 
Tables 6.1 and 6.2 summarizes the concentration of the most abundant compounds 
(inorganic and organic compounds respectively) found in saliva of healthy people
[128]
. 
 
Table 6.1: concentrations of the most abundant inorganic compounds 
 
Compounds Concentration (mM) 
Chloride
 
6.5-42.9 
Phosphate
 
1.89-5.53 
Bicarbonate 6.7-22.1 
Thiocyanate 0.41-6.55 
Potassium 11-23 
Sodium 5.2-24.4 
Calcium 0.69-2.46 
Magnesium 0.065-0.38 
 
 
Table 6.2: concentrations of the most abundant organic compounds 
 
Compounds Concentration (mM) 
Urea 2.4-12.5 
Amino acids 0.74 
Choline 0.04-0.3 
Lactic acid 0.11-0.56 
Pyruvic acid 0.01-0.07 
Citric acid 0-0.1 
Lipids 20-28 mg/L 
Proteins (total) 1.4-6.4 g/L 
Carbohydrates (total) 154-334 mg/L 
 
 
The correlation between salivary and blood lactate has been studied in several works as it 
represents an attractive alternative to the invasive blood analysis.  
Salivary lactate is possibly formed by passive diffusion from blood and salivary glands
[130]
. 
Shannon et al. suggested that the salivary lactate increases because of an increase in the 
concentration of blood lactate, which leads to an increase in the permeability of the blood-
saliva barrier
[131]
.  However a blood lactate threshold was found (3 mmol/L), below which 
the changes in blood lactate concentration apparently are not reflected in salivary 
concentration during a 30-Km race
[132, 133]
.   
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The results of these studies suggest that the salivary lactate has a high correlation with the 
concentration of blood lactate during exercise of various intensities, duration and muscle 
groups involved, and it does not depend on temperature and relative air humidity.  
 
 
6.1. Application of the method to saliva samples 
 
The optimized method was successfully applied to saliva samples collected before, during 
and after training. 
The use of saliva samples to monitor the athletes during training it’s very attractive 
because the samples can be collected many times during the training and not only before 
and after the training as for urine samples.  This allows to determine the lactate 
concentration at every step of the training and to find out the switch of cell metabolism 
from aerobic to anaerobic (aerobic-anaerobic threshold).  This parameter, as well as the 
blood lactate measure during graded incremental exercise tests, or the maximum oxygen 
consumption and heart rate, may contribute to evaluate aerobic endurance performance 
capacity and to determine the optimal work load intensities during endurance training.  
 
 
6.1.1. Dilution of the samples and matrix effect 
 
The presence of proteins in saliva samples affects the analysis by HPLC because they can 
precipitate in the column.  Therefore a dilution of the samples is required, as in the case of 
urine samples. 
A pooled saliva sample was diluted 50 times (as urine samples) and the analytical addition 
method was carried out in order to study the matrix effect. 
The analytical addition method slope was found to be (3.31±0.03)·10
7
 (R
2
 = 0.999), 
indicating that no matrix effect occurs.  
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6.1.2. Analytical figures of merit 
 
Repeatability and recovery were calculated in order to estimate the precision and the 
accuracy of the method.  Intra-day repeatability was calculated as the RSD% of the 
concentrations of lactate found in the saliva sample as such and in the same saliva sample 
with different spikes of a lactate standard solution (LQC, MQC and HQC).  Intra-day 
recoveries were calculated as the percentage ratio of the concentration of lactate in a spiked 
saliva sample after subtraction of the endogenous lactate concentration, with respect to the 
nominal concentration of lactate added to the sample.  
Table 6.3 summarizes the intra-day repeatability and recoveries for three different spike 
levels in a pooled saliva sample. 
 
Table 6.3: intra-day repeatability and recoveries for three different spike levels in a pooled saliva sample 
 
Lactate spike 410 nm 365 nm 
Intra-day repeatability   
0 2% 3% 
LQC (0.0003 mM) 2% 2% 
MQC (0.001 mM) 1% 3% 
HQC (0.01 mM) 1% 1% 
Intra-day recovery   
0 / / 
LQC (0.0003 mM 108% 109% 
MQC (0.001 mM) 101% 106% 
HQC (0.01 mM) 102% 104% 
 
 
6.1.3. Salivary lactate during training 
 
The optimized method was applied to three healthy volunteers to study the trend of the 
salivary lactate during training.   
Figure 6.2 A), B) and C) shows the trend of salivary lactate in three different athletes 
during different training sessions.   
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Fig. 6.2: trend of the salivary lactate concentration during different training sessions for three different 
athletes: A) 27 years old girl, B) 45 years old woman, C) 27 years old boy 
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For the first two athletes the lactate concentration in saliva before-training was found to be 
lower than the limit of quantification of the method.  
For the first athlete (Figure 6.2 A)) the salivary lactate concentration reached 0.27 mM 
after 50 minutes of a cardio training session.  This session was followed by a 30 minutes of 
soft workout session in which the salivary lactate concentration fell under the LOQ.  The 
final session consisted in another 50 minutes cardio session in which the salivary lactate 
increased to 0.26 mM. 
In the athlete of Figure 6.2 B) the lactate in saliva had a trend related to the intensity of the 
exercise (Watt of cicloergometer). 
The athlete of Figure 6.2 C) performed a pyramidal work out with leg extension increasing 
the weight lifted.   
The results indicate that the performance of athletes can be monitored by measuring the 
salivary lactate during training.   
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Conclusions 
 
In this work we developed a novel and straightforward method for the determination of 
lactate in urine and saliva samples by HPLC-DAD/FD.  The derivatization of lactate was 
mandatory to achieve the selectivity and sensibility required for the application of the 
method to complex matrices.  
The novelty of this work is the derivatization of lactate with 9-chloromethyl anthracene (9-
CMA) without any extraction procedure, with yields higher than 70 %.  9-CMA was 
employed in previous works for the derivatization of several organic, fatty and bile acids, 
but never investigated as derivatization agent for lactate.   
First, the derivatization reaction was studied in pure organic medium (ACN) and in the 
presence of trace of water in the reaction medium.  The high derivatization yield (> 70 %) 
indicated that the extraction of lactate from the aqueous phase could be avoided.  We also 
observed the formation of 9-hydroxymethyl anthracene, resulting from the partial 
hydrolysis of the lactate derivative in the reaction medium; a side reaction that could be 
controlled.  Thus, the derivatization procedure was optimized.  A central composite design 
was carried out in order to find the optimal temperature and reaction time for the reaction 
between lactate and 9-CMA.  A Doehlert design was carried out to study simultaneously 
the effect of the concentration of TEA, TBAB and 9-CMA on the derivatization of a lactate 
standard solution.  The derivatization yield increased as the TBAB and 9-CMA 
concentration increased.  The TEA concentration was found to be a critical parameter 
because TEA reacts with 9-CMA.  
The anthracene derivatives were characterized by HPLC-ESI-Q-ToF and the formation of 
the lactate derivative was proved.  The MS and MS/MS spectra also showed the formation 
of the 9-OHMA and of a 9-TEA-MA adduct. 
The chromatographic conditions were optimized in order to find the best column, column 
temperature and mobile phase able to guarantee a good resolution and a short time of 
analysis.  A further optimization of the elution method was required to get the 
simultaneous determination of the lactate derivative with creatinine for the application of 
the method in urine samples.  
Development of a chromatographic method for the determination of lactate in urine and saliva 
100 
 
The detection of the lactate derivative was achieved both in absorbance (365 nm) and in 
fluorescence (λex = 365 nm; λem = 410 nm) and the creatinine was detected at 234 nm. 
The calibration curve was linear in the investigated range 0.09-15 mM and the limit of 
detection was 0.03 mM for both fluorescence and UV detection. 
The optimized method was successfully applied to urine and saliva samples from healthy 
volunteers before, after and during training in order to study the endurance performance. 
The increase in the lactate concentration in the post training urine samples was found to be 
related to the type of training, indicating that not only the blood lactate, but also the urinary 
lactate concentration can be used to estimate the endurance performance of athletes during 
training.  The determination of salivary lactate was found to be very useful because 
provided a monitoring of the performance not only before and after training but also during 
training.   
The method was also applied to urine samples from patients of an intensive care unit and 
the results indicated that the optimized method allow the monitoring of the urinary lactate.  
Currently we found a correlation between the urinary lactate and lactemia on the four 
samples analyzed (R
2
 = 0.977).  This study is in progress in order to confirm this 
correlation on a significant number of samples.  This correlation would be useful in order 
to understand if the urinary lactate concentration can be used as a prognostic marker of 
respiratory failure. 
The optimized method was found to be fast, simple and competitive with the other RP-
HPLC methods for the determination of lactate.  This is also the first method reported in 
the literature able to guarantee the simultaneous determination of lactate and creatinine.   
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Abbreviations 
 
(+)-FLEC: (+)-1-(9-fluorenyl)-ethyl-chloroformate 
2-DBAP: 2,4’-dibromo-acetophenone 
2-HP-β-CD: 2-hydroxypropyl-β-cyclodextrin  
9-CMA: 9-chloromethyl anthracene 
9-OHMA: 9-hydroxymethyl anthracene 
α-BAP: α-bromo-acetophenone 
ATP: adenosine triphosphate 
BE: base excess 
BSTFA: N,O-bis-(trimethylsilyl)-trifluoro-acetamide 
CE: capillary electrophoresis  
DAD: diode array detector 
DATAN: (+)-O,O’-diacetyl-L-tartaric anhydride  
DBD-PZ: -(N,N-dimethylaminosulfonyl)-7-piperazino-2,1,3-benzoxadiazole 
FD: fluorescence detector 
FL: fluorescence 
GC/MS: gas chromatography-mass spectrometry 
Hct: hematocrit 
HPLC: high performance liquid chromatography 
HQC: high quality control 
IEC: ion-exchange chromatography 
LC-ESI-q-ToF: liquid chromatography-electronspray ionization-quadrupole-time of flight 
LC-MS/MS: liquid chromatography-tandem mass spectrometry 
LDH: lactate dehydrogenase 
LOX: lactate oxidase  
LQC: low quality control 
MLST: maximum lactate steady state 
MQC: medium quality control 
NAD
+
: nicotinamide adenine dinucleotide  
NBD-PZ: 4-nitro-7-piperazino-2,1,3-benzoxadiazole 
NBD-PZ-Val: 2S)-2-amino-3-methyl-1-[4-(7-nitro-benzo-2,1,3-oxadiazol-4-yl)-piperazin-1-yl]-butan-1-one 
PNBDI: O-(4-nitrobenzyl)-N,N’-diisopropylisourea 
RP: reversed-phase  
RSD%: relative standard deviation percent 
TBAB: tetra-n-butylammonium bromide 
TEA: triethanolamine 
tHb: total hemoglobin 
VO2max : maximum oxygen consumption 
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